TSS:Rfhg 212003.1

Basic information about the TSS

---

TSS ID: rfhg_212003.1 Species: human Chr: chr19		Start: 39436037 End: 39436040 Strand: -
Source datasets	PRJNA401781
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3061118,EH38E1953379)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000251453.8:88 GeneID: 6217 HGNC/MGI_ID: HGNC:10396 UniProt_ID: P62249 Nearer transcript ids and distances: ENST00000601390.1:89 AK055869:89 AK315498:89 D28392:89 BC004324:91 ENST00000601655.5:96 BC095429:96 ENST00000339471.8:101 M60854:103 BC007977:106 BC071674:106 BC024970:121 ENST00000599539.5:122 DQ893449:140 DQ896219:140 CU678668:141 KJ892061:141 KJ905911:141 CU687136:141 KJ901716:141 ENST00000599705.1:332 view more...

Gene_name: ribosomal protein S16 Gene_symbol: RPS16 Gene_synonyms: S16 Gene_source: HGNC:10396

TATA-Box annotation

---

Distance to TSS:	-89
Nearest PromoterID:	NM_001321111
Entrez ID:	6217
Nearest Unigene:	Hs.397609
Nearest Refseq:	NM_001020
Nearest Ensembl:	ENSG00000105193
Gene Name:	ribosomal protein S16
Gene Alias:	S16
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.250000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RPS16 p2@RPS16 p3@RPS16 p4@RPS16 p6@RPS16 p7@RPS16
Sample		p1@RPS16	p2@RPS16	p3@RPS16	p4@RPS16	p6@RPS16	p7@RPS16
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	845.84	99.15	1.75	3.31	0.39	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	948.27	119.17	4.05	1.62	0.40	1.01
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	918.80	118.64	2.31	1.74	0.39	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	807.31	92.10	2.91	2.91	0.21	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	871.97	101.68	2.25	1.80	0.00	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	955.49	114.15	1.55	1.16	0.19	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	1387.26	153.39	4.14	2.18	0.44	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	1091.93	121.84	2.66	0.97	0.73	0.97
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	1138.90	127.38	2.14	1.28	0.21	1.28
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	1010.29	55.06	2.32	3.48	1.74	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	869.51	40.83	2.02	0.81	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	817.58	44.72	2.44	1.63	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	1060.49	22.24	4.84	1.77	0.16	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	1090.49	22.55	3.76	2.56	0.00	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	948.91	21.74	5.49	3.95	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	992.13	25.40	4.53	2.26	0.50	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	1002.93	25.12	1.97	1.31	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	1011.09	21.09	5.06	2.11	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	960.74	30.39	1.60	3.73	1.07	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	1270.48	30.99	5.27	4.51	0.30	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	1213.96	30.47	4.54	2.54	0.27	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	1275.86	31.24	5.18	3.97	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	1050.47	26.76	2.33	2.33	0.00	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	1042.01	23.54	2.43	2.91	0.73	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	1152.18	26.06	3.87	2.06	0.52	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	1246.74	27.54	5.38	1.58	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	1123.10	33.52	3.30	4.40	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	1495.62	30.41	2.83	3.54	0.24	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	1286.53	37.96	5.33	3.07	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	1080.55	34.02	4.52	2.53	0.18	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	978.26	30.15	3.35	3.98	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	1103.13	29.31	4.49	3.71	0.20	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	1237.48	40.73	3.38	2.32	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	1463.35	48.99	4.95	3.13	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	1145.50	28.80	3.93	3.37	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	1065.62	26.25	1.72	1.15	0.19	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	1179.27	30.25	3.07	3.27	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	1120.47	33.45	4.03	3.02	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	1083.92	36.19	4.59	4.32	0.54	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	999.86	34.09	4.32	1.92	0.00	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	1123.37	32.00	2.35	2.82	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	1171.45	38.94	6.29	3.07	0.15	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	1062.06	29.74	3.59	4.85	0.42	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	1045.29	36.01	3.50	2.62	0.35	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	1076.54	36.14	2.41	3.81	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	1050.40	29.31	5.35	5.58	0.70	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	942.35	29.27	3.12	2.88	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	1085.50	39.94	7.15	2.68	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	1048.70	29.68	4.07	2.15	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	1095.91	34.98	4.65	3.64	0.20	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	817.15	26.64	8.61	11.89	0.20	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	893.50	34.02	4.67	6.45	0.44	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	545.70	13.99	13.99	0.00	13.99	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	818.30	34.07	6.03	4.26	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	873.86	30.16	3.65	6.30	0.00	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	1090.62	52.01	5.87	3.36	0.84	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	840.87	43.63	11.02	11.02	0.46	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	772.35	30.79	5.19	3.89	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	737.08	23.12	3.21	1.61	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	1072.18	34.26	10.69	10.06	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	857.35	26.09	2.12	0.71	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	763.23	19.07	3.36	5.05	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	792.16	15.92	8.76	25.48	1.59	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	798.11	18.01	5.78	9.85	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	659.91	20.79	2.92	3.57	0.32	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	711.38	15.26	3.90	6.74	0.35	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	614.23	16.16	0.00	0.00	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	513.34	15.79	0.00	0.00	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	556.74	14.14	2.44	2.93	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	630.75	24.79	2.98	3.47	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	699.45	20.64	0.00	2.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	576.93	16.56	3.31	3.97	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	476.39	13.61	5.57	4.33	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	518.85	11.62	1.83	1.22	0.00	0.61
Adipocyte - breast, donor1	11376-118A8	428.59	27.88	0.63	0.32	0.32	0.00
Adipocyte - breast, donor2	11327-117E4	321.82	18.45	1.28	2.25	0.16	0.00
Adipocyte - omental, donor1	11473-119C6	352.42	23.28	0.51	0.13	0.89	0.38
Adipocyte - omental, donor2	11474-119C7	291.52	21.68	2.24	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	318.84	18.76	1.34	1.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	401.30	24.88	1.91	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	690.49	37.38	7.70	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	547.37	69.10	0.90	0.90	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	1100.87	19.29	4.52	1.04	0.00	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	588.08	16.23	0.59	0.59	0.78	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	382.21	28.05	0.77	0.77	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	534.96	26.76	0.84	0.56	0.56	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	431.45	24.69	1.76	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	499.49	13.75	0.56	0.24	0.24	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	413.13	22.92	0.97	1.61	0.00	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	469.21	16.00	2.67	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	355.01	25.60	0.56	0.56	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	354.76	8.32	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	336.56	19.59	1.00	1.26	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	324.30	21.27	0.33	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	215.87	17.66	1.22	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	670.51	96.80	0.22	0.44	0.88	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	892.87	139.85	3.94	1.79	0.72	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	820.64	17.97	3.59	1.20	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	634.53	44.44	0.36	0.72	1.08	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	871.89	23.43	1.67	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	743.31	32.67	1.64	1.03	0.00	0.62
Anulus Pulposus Cell, donor1	11248-116E6	919.87	29.18	0.46	0.46	0.11	0.92
Anulus Pulposus Cell, donor2	11463-119B5	597.33	29.88	1.22	1.71	0.24	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	533.31	46.73	0.90	0.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	549.62	36.90	0.87	0.87	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	847.54	32.10	4.28	2.14	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	476.48	35.87	2.09	1.20	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	494.48	46.79	0.00	2.53	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	716.84	42.90	0.66	5.28	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	499.67	36.71	1.62	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	617.48	31.07	2.43	0.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	724.53	30.88	1.78	1.78	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	522.77	36.16	2.26	0.38	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	634.96	36.28	0.00	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	842.54	23.82	0.00	2.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	748.23	30.15	0.49	0.33	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	873.47	38.21	2.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	679.92	38.30	0.75	1.51	1.21	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	600.08	40.18	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	645.22	31.17	0.94	0.76	0.19	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	648.97	27.80	3.21	1.34	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	694.52	28.29	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	629.93	32.67	1.33	0.66	0.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	809.29	38.42	1.20	2.40	2.40	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	863.80	28.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	589.55	31.56	1.89	1.37	0.17	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	633.44	41.95	0.00	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	575.23	29.13	1.46	1.46	0.00	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	690.22	36.43	0.76	0.38	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	725.61	26.65	6.06	7.27	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	627.04	39.33	1.14	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	626.36	26.94	0.43	0.64	0.00	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	695.04	30.45	1.29	1.55	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	608.09	36.60	2.82	1.41	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	628.95	39.55	1.61	0.64	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	752.69	39.95	1.43	2.14	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	529.97	38.02	2.34	1.17	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	626.53	32.52	1.51	0.60	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	785.26	26.14	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	625.02	46.79	2.54	1.53	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	716.95	37.95	2.04	1.53	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	752.28	35.58	1.27	3.18	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	588.61	27.19	1.73	0.86	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	658.98	35.35	0.64	0.64	0.21	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	720.02	32.48	0.58	1.74	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	662.26	34.96	0.94	4.72	0.00	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	630.12	31.70	0.68	1.36	0.17	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	741.24	20.85	4.63	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	925.31	42.25	0.00	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	576.55	34.95	1.07	0.86	0.64	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	736.44	36.70	2.41	1.20	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	604.32	44.47	1.46	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	711.02	30.80	1.84	1.15	0.69	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	640.13	30.60	7.65	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	735.74	37.88	1.02	0.00	1.02	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	669.28	30.14	1.24	0.83	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	703.80	30.91	2.14	1.22	0.92	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	581.74	32.98	3.82	2.87	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	619.10	33.48	1.33	1.11	0.00	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	799.52	24.41	1.53	1.53	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	640.29	34.89	1.66	1.11	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	625.44	27.54	1.32	0.53	0.26	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	694.55	38.53	1.09	0.73	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	534.25	76.39	0.37	0.86	2.33	0.37
Astrocyte - cerebellum, donor2	11580-120F5	709.46	98.07	1.03	2.05	0.00	0.51
Astrocyte - cerebellum, donor3	11661-122F5	901.49	62.29	1.68	1.26	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	732.03	51.59	0.35	0.35	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	753.70	75.22	1.94	1.62	0.49	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	801.59	55.49	1.49	1.49	0.00	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	956.59	72.83	1.72	1.38	0.34	0.92
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	886.99	92.33	1.00	0.88	0.63	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	839.59	86.60	1.37	1.02	1.37	0.34
Basophils, donor1	12241-129G9	717.65	46.29	0.26	0.26	0.00	0.00
Basophils, donor2	12242-129H1	1160.68	72.16	0.00	1.08	0.72	0.00
Basophils, donor3	12243-129H2	982.82	56.59	0.15	0.29	0.59	0.59
Bronchial Epithelial Cell, donor1	11511-119G8	927.74	54.33	0.43	0.65	0.65	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	1080.33	37.95	2.29	1.83	0.00	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	1362.98	43.04	0.00	21.52	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	689.79	100.42	2.51	1.88	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	665.86	93.16	1.25	1.46	0.21	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	642.05	41.22	3.45	1.61	0.23	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	778.98	35.45	1.62	1.44	0.72	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	1542.84	259.49	0.41	0.52	0.10	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	1928.68	156.74	1.40	2.10	3.03	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	2704.66	136.86	1.28	0.96	0.00	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	2130.44	113.76	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	674.58	16.91	0.56	0.00	0.56	1.13
CD14+ Monocytes, donor2	11305-117B9	648.30	25.61	1.67	0.56	0.56	0.74
CD14+ Monocytes, donor3	11381-118B4	844.56	34.03	2.85	1.32	0.00	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	643.08	8.21	0.00	0.28	0.57	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	620.17	17.44	1.14	0.38	1.52	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	658.47	14.46	0.66	0.33	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	583.98	22.69	1.73	1.45	0.43	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	480.68	30.78	0.91	1.21	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	428.07	21.08	0.71	1.42	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	489.64	20.09	1.51	1.67	0.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	487.44	26.22	1.38	2.48	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	466.85	24.05	0.25	1.24	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	661.02	35.44	2.74	1.96	0.00	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	702.05	52.70	1.07	2.49	0.53	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	1027.43	59.85	0.65	1.09	0.87	1.96
CD14+ monocytes - treated with Candida, donor1	11868-125B5	612.24	25.05	0.70	0.47	0.47	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	683.80	41.71	1.58	1.06	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	643.43	26.62	1.11	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	562.27	21.12	1.19	1.49	0.45	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	484.50	36.92	1.40	2.00	0.00	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	853.41	37.27	0.62	0.62	0.21	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	716.78	29.51	1.83	2.52	0.46	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	720.01	58.59	1.36	0.90	1.36	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	481.42	27.50	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	557.88	34.16	1.08	2.69	0.81	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	789.43	68.56	2.09	4.54	0.35	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	576.95	49.24	1.26	0.42	1.26	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	498.41	18.74	0.18	0.18	0.00	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	534.03	28.53	1.41	1.41	0.70	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	418.11	22.81	0.00	2.19	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	569.33	31.04	1.92	2.62	0.17	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	649.69	45.34	1.49	1.49	0.37	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	994.33	68.33	0.86	1.29	1.29	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	446.75	20.06	1.23	4.09	1.23	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	598.74	31.52	0.23	0.93	0.93	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	808.26	28.30	0.23	0.70	0.93	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	828.48	33.13	1.09	0.87	0.44	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	964.40	36.27	1.85	1.15	0.92	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	1307.93	64.98	1.08	0.43	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	1090.68	35.19	0.62	0.78	0.62	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	863.44	35.45	0.70	0.70	0.87	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	698.79	45.04	0.00	0.00	1.11	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	1421.83	33.43	0.77	0.51	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	913.61	20.86	0.44	0.88	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	1444.13	32.21	0.84	0.84	0.42	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	3985.36	42.68	0.00	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	4004.14	52.88	1.36	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	4263.56	34.17	1.04	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	3835.74	43.18	1.60	1.60	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	4403.26	38.06	5.36	2.14	0.54	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	3852.94	41.41	2.11	0.70	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	4348.46	57.26	0.78	0.00	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	5070.13	64.60	1.32	0.00	2.64	1.32
CD19+ B Cells, donor1	11544-120B5	1870.65	33.70	4.11	4.93	3.29	2.47
CD19+ B Cells, donor2	11624-122B4	1807.77	63.11	3.63	4.35	2.18	1.45
CD19+ B Cells, donor3	11705-123B4	1615.95	66.13	4.54	1.01	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	822.26	89.30	0.81	0.81	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	828.14	80.30	0.40	0.40	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	1833.39	59.24	6.02	2.01	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	1293.28	62.36	1.69	0.56	0.00	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	2024.57	133.02	0.38	0.75	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	2376.14	156.94	1.35	0.45	0.68	0.00
CD4+ T Cells, donor1	11225-116C1	2502.61	54.63	2.50	0.36	1.43	0.71
CD4+ T Cells, donor2	11306-117C1	3095.50	88.79	9.19	8.57	0.61	1.84
CD4+ T Cells, donor3	11382-118B5	2270.37	71.67	8.23	4.27	0.30	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	1374.19	25.52	0.00	0.77	0.77	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	1878.08	24.03	0.67	1.35	2.92	3.14
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	1739.42	32.48	1.15	0.86	2.87	1.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	5197.46	30.34	1.42	5.22	1.42	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	6714.20	34.41	4.92	3.51	0.70	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	3764.29	52.74	6.59	6.59	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	897.58	27.31	1.30	1.30	0.43	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	1203.86	32.71	2.71	3.73	1.19	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	993.19	46.75	1.93	1.77	1.13	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	2074.28	46.17	2.69	1.34	1.34	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	2269.63	45.42	1.40	2.45	0.70	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	1601.97	46.20	0.88	0.88	2.20	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	1234.14	34.57	2.53	0.84	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	1425.51	32.62	2.91	2.29	1.04	1.87
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	1466.15	49.79	1.67	4.34	1.67	1.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	3879.69	18.76	1.63	4.62	2.18	1.63
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	3985.32	22.51	3.22	3.22	1.61	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	3066.42	35.86	7.17	8.97	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	1467.85	57.48	0.56	1.11	1.30	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	1305.55	44.62	1.30	0.65	6.72	5.63
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	1079.13	49.18	1.47	0.42	4.62	2.31
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	3854.73	55.11	2.02	2.53	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	4083.83	47.22	3.03	1.73	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	2410.06	60.14	1.74	1.31	3.05	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	5155.05	60.37	2.47	3.46	2.97	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	4380.51	57.24	0.00	1.85	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	5629.35	60.02	2.79	2.79	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	2333.68	35.17	1.38	0.55	0.55	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	2486.30	29.69	2.70	0.74	0.00	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	3118.51	18.48	6.16	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	4140.91	43.69	0.72	1.79	0.72	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	5451.33	54.01	1.38	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	1940.80	79.56	1.96	1.31	1.64	1.64
CD8+ T Cells, donor2	11307-117C2	1974.77	102.12	6.76	4.51	0.38	1.13
CD8+ T Cells, donor3	11383-118B6	2503.43	74.48	3.79	3.53	1.01	1.51
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	553.98	77.99	0.92	1.38	0.46	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	485.52	67.82	0.48	0.48	0.00	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	683.16	82.90	1.92	1.37	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	824.98	107.18	1.20	1.80	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	526.04	64.08	1.20	0.72	0.48	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	546.86	65.03	0.23	1.59	0.00	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	624.47	106.90	0.65	1.30	0.00	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	592.21	104.23	1.32	1.58	0.53	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	557.68	97.56	1.64	1.17	0.47	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	677.11	120.75	0.91	2.11	0.60	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	707.96	109.81	0.87	2.32	0.00	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	745.48	116.70	0.53	0.53	0.00	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	583.96	26.27	0.00	0.00	0.00	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	659.46	30.51	0.46	0.91	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	416.20	29.83	2.24	0.75	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	708.07	80.31	1.44	0.36	0.36	1.80
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	639.03	73.08	0.86	1.15	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	692.01	65.05	0.71	0.24	0.71	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	705.43	131.52	0.95	0.32	0.00	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	673.56	115.64	1.85	1.54	0.92	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	653.67	113.17	0.32	0.64	0.32	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	709.47	96.00	1.53	0.76	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	672.74	91.04	0.79	0.39	0.00	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	625.55	98.33	0.76	0.00	0.76	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	524.33	22.48	0.80	0.80	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	578.43	21.68	1.40	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	548.96	22.04	2.00	3.01	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	283.30	20.11	0.00	0.00	1.83	3.66
Cardiac Myocyte, donor2	11605-120I3	779.67	59.78	0.49	0.00	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	1146.82	55.35	0.11	0.53	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	319.97	44.72	0.35	0.00	3.12	1.39
Chondrocyte - de diff, donor2	11338-117F6	637.55	31.98	1.07	1.42	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	737.97	25.49	1.71	1.48	0.11	0.57
Chondrocyte - re diff, donor2	11339-117F7	367.06	39.39	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	608.22	22.24	0.81	1.21	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	1011.59	55.31	1.15	0.69	1.03	1.38
Ciliary Epithelial Cells, donor2	11323-117D9	822.57	54.94	2.78	1.50	1.28	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	739.84	58.23	1.50	0.62	0.09	0.62
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	573.22	16.41	0.37	0.18	0.28	0.09
Corneal Epithelial Cells, donor1	11526-119I5	876.31	52.04	0.44	0.66	0.88	0.22
Corneal Epithelial Cells, donor2	11606-120I4	828.17	80.77	2.28	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	781.72	78.22	2.05	1.28	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	367.01	17.34	0.33	0.50	0.99	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	388.58	17.03	0.32	0.00	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	652.18	20.70	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	287.25	10.69	0.97	0.43	0.00	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	1537.73	23.57	2.05	1.37	0.68	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	2989.49	33.95	0.65	1.31	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	1365.69	29.52	0.97	2.42	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	705.60	104.23	0.33	0.17	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	497.59	103.27	1.17	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	555.70	91.91	1.13	0.28	0.57	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	574.44	90.83	0.00	1.18	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	564.59	119.55	1.16	0.29	0.29	0.58
Endothelial Cells - Artery, donor2	11341-117F9	579.02	148.23	1.65	1.65	0.00	0.47
Endothelial Cells - Artery, donor3	11413-118E9	733.67	127.80	1.58	0.35	0.18	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	546.82	47.66	0.22	0.89	0.66	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	370.60	40.16	0.00	0.30	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	219.32	32.42	0.00	0.28	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	526.52	59.13	0.30	0.30	1.78	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	854.41	108.30	4.69	0.00	2.60	1.56
Endothelial Cells - Microvascular, donor3	11414-118F1	865.75	47.22	2.69	2.41	0.00	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	489.35	117.24	1.20	1.20	2.00	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	498.44	109.54	2.10	3.67	0.52	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	684.47	98.40	0.12	0.62	0.99	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	522.73	68.65	0.43	0.43	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	516.72	84.15	0.73	0.37	0.24	0.24
Endothelial Cells - Vein, donor1	11267-116G7	615.39	164.94	0.00	1.14	0.00	2.28
Endothelial Cells - Vein, donor2	11344-117G3	514.10	103.38	0.70	0.00	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	742.96	102.68	0.79	1.73	0.00	0.31
Eosinophils, donor1	12244-129H3	1235.00	76.23	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	374.61	28.05	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	331.71	0.00	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	810.19	67.19	0.00	0.98	0.73	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	1010.96	43.68	0.00	4.16	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	1334.04	48.81	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	406.82	18.06	0.82	1.64	0.82	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	484.38	49.16	5.80	4.27	0.55	3.39
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	921.09	71.29	4.77	2.60	0.22	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	694.69	77.62	1.33	0.24	0.36	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	157.62	26.20	0.14	0.00	0.00	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	529.03	28.16	1.27	1.05	0.21	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	132.27	23.71	0.26	0.26	0.00	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	614.57	71.42	2.66	0.66	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	658.21	61.69	1.36	1.81	0.00	2.27
Fibroblast - Cardiac, donor2	11345-117G4	551.03	47.75	0.00	0.76	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	795.05	73.50	1.73	2.21	0.32	0.32
Fibroblast - Cardiac, donor4	11452-119A3	430.41	30.01	0.61	0.00	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	550.51	42.13	1.02	1.02	0.13	0.63
Fibroblast - Cardiac, donor6	11460-119B2	550.59	65.49	2.12	1.21	0.45	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	491.34	18.62	0.40	0.13	1.88	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	524.19	27.61	0.86	2.59	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	719.21	61.52	0.00	2.93	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	759.96	52.12	0.00	0.46	1.15	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	1132.11	8.48	0.51	0.17	2.88	0.17
Fibroblast - Dermal, donor1	11269-116G9	688.85	67.15	2.11	0.94	0.23	0.47
Fibroblast - Dermal, donor2	11346-117G5	679.22	113.67	0.00	0.94	0.00	1.42
Fibroblast - Dermal, donor3	11418-118F5	953.67	60.44	2.42	1.45	0.48	1.33
Fibroblast - Dermal, donor4	11450-119A1	580.38	53.92	1.81	1.81	0.11	0.90
Fibroblast - Dermal, donor5	11454-119A5	645.13	73.10	1.92	1.05	0.52	0.87
Fibroblast - Dermal, donor6	11458-119A9	629.39	81.05	2.44	1.30	0.65	1.14
Fibroblast - Gingival, donor1	11237-116D4	736.30	34.15	0.83	0.21	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	553.87	32.49	1.05	0.52	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	871.22	63.39	1.58	3.29	0.13	0.40
Fibroblast - Gingival, donor3	11394-118C8	741.01	11.51	0.48	0.58	0.00	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	413.48	21.82	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	494.60	13.57	2.47	1.23	0.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	754.85	80.44	0.62	0.16	0.16	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	581.61	59.50	0.81	0.27	0.27	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	272.78	34.23	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	601.06	55.43	1.46	0.00	0.15	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	725.13	40.77	0.95	0.27	0.27	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	803.39	52.76	1.54	1.54	0.00	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	906.55	10.86	2.20	0.88	0.00	0.44
Fibroblast - Lung, donor1	11270-116H1	698.71	58.45	1.36	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	432.72	31.34	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	858.07	74.50	1.27	0.84	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	462.33	59.98	0.00	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	497.91	27.97	0.00	4.20	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	476.91	22.95	0.56	0.56	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	661.73	87.28	0.81	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	730.94	91.87	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	571.80	41.69	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	936.70	64.01	0.19	0.19	0.58	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	696.07	47.78	1.21	1.21	0.00	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	350.97	41.00	0.61	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	364.45	38.16	1.53	1.14	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	658.24	32.94	2.70	2.16	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	491.03	15.31	0.35	1.16	0.12	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	837.73	119.93	0.55	0.55	0.77	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	615.67	41.65	0.41	0.41	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	884.70	72.83	0.67	2.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	1054.82	58.51	1.19	0.00	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	108.35	11.51	0.20	0.00	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	662.34	13.14	0.36	0.18	1.07	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	701.03	29.17	0.39	0.00	1.38	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	168.18	22.26	0.30	0.60	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	472.83	20.19	0.43	0.32	0.11	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	146.02	12.15	0.25	0.25	0.25	0.25
Fibroblast - skin normal, donor1	11553-120C5	475.33	22.48	0.33	0.16	1.64	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	180.66	23.66	0.00	0.00	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	371.81	24.01	0.20	0.50	0.30	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	101.25	17.23	0.30	0.30	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	801.95	14.75	0.33	0.33	2.98	1.16
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	816.63	13.16	0.51	0.34	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	76.85	18.39	0.00	0.66	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	355.36	33.34	0.43	0.32	0.11	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	497.10	61.91	0.51	0.34	0.67	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	798.06	34.19	3.92	1.41	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	288.08	22.16	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	578.70	30.50	0.87	1.74	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	585.78	32.59	0.35	0.69	0.87	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	481.97	47.62	0.26	0.26	0.26	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	391.96	49.57	0.51	1.02	0.77	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	1536.46	155.41	19.14	8.42	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	1638.57	194.61	9.57	7.02	1.28	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	1995.71	152.33	10.84	5.99	0.00	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	1823.86	39.16	8.55	5.24	0.83	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	959.88	43.61	5.02	1.60	0.68	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	1432.48	99.86	5.55	4.36	0.40	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	1719.23	41.50	7.67	5.02	0.79	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	936.04	51.21	4.57	1.63	0.65	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	1705.66	122.05	7.08	5.75	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	1143.72	107.26	1.98	2.26	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	1001.02	87.18	2.34	2.09	0.37	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	989.08	125.45	2.69	1.34	0.27	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	904.42	51.29	0.99	1.73	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	1100.90	56.48	1.25	1.80	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	929.50	71.36	3.05	2.03	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	823.50	41.30	1.60	1.14	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	884.67	33.76	2.24	1.25	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	747.31	37.60	2.84	1.97	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	1066.09	43.14	4.43	0.89	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	933.72	46.73	1.75	2.07	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	835.81	45.58	0.89	1.34	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	917.03	37.10	1.81	1.41	0.20	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	876.88	55.13	2.37	1.02	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	682.78	59.59	0.71	0.18	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	968.76	39.85	1.04	0.21	0.10	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	733.31	44.40	0.85	0.17	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	946.20	42.49	1.66	0.77	0.33	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	764.16	55.49	0.00	0.17	0.25	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	628.88	71.67	0.61	0.41	1.23	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	981.60	36.10	1.86	1.44	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	912.89	32.97	1.61	1.84	0.23	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	806.81	57.37	1.17	1.00	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	993.04	27.11	1.76	1.10	0.88	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	1194.74	39.85	3.07	2.83	0.12	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	779.99	71.00	1.46	0.65	0.16	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	1122.82	34.00	1.92	3.21	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	842.75	36.01	1.42	1.14	0.47	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	885.15	50.30	1.74	1.42	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	859.96	41.96	3.95	1.22	0.61	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	779.54	51.43	1.15	2.09	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	875.80	43.47	1.54	0.88	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	743.17	40.12	0.84	1.40	0.84	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	404.14	49.26	0.46	0.83	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	582.14	80.76	1.34	1.87	0.53	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	467.58	63.50	0.61	1.38	0.15	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	589.91	61.53	1.55	1.04	0.26	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	624.55	50.15	0.27	0.00	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	563.56	32.45	0.74	0.74	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	612.10	32.68	0.88	0.66	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	339.18	9.92	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	470.66	32.71	1.06	0.66	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	505.81	31.68	0.81	1.21	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	302.96	11.95	0.00	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	784.30	92.76	2.99	1.00	0.40	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	1145.25	111.24	2.31	1.39	0.00	1.39
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	1242.84	118.86	1.84	0.41	0.20	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	1777.76	175.87	1.88	1.25	6.57	8.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	1844.52	172.92	1.70	2.54	5.37	8.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	972.22	118.53	3.23	2.77	3.23	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	1804.13	160.86	12.37	7.42	0.00	7.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	1264.48	146.99	3.87	5.42	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	1768.12	137.98	9.63	11.23	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	1264.13	107.81	8.69	1.74	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	1219.24	97.64	4.56	4.23	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	1110.63	101.30	4.94	2.47	0.41	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	1092.98	86.64	19.99	13.33	0.00	10.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	1131.17	74.11	2.80	1.68	0.56	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	1065.51	84.65	2.94	3.92	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	1072.87	48.65	5.03	5.03	3.36	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	1217.58	62.34	5.73	2.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	1227.20	79.82	2.38	3.06	0.34	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	1971.21	66.82	2.09	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	1729.55	58.42	4.01	5.15	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	1228.63	52.39	2.66	2.37	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	1485.76	89.79	5.08	5.08	1.69	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	1267.06	90.30	3.31	5.38	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	1182.63	92.74	2.53	3.45	0.69	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	1638.50	121.18	5.27	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	1157.85	59.58	1.15	3.84	0.38	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	1159.15	54.76	3.26	2.93	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	1793.16	56.85	12.71	4.68	0.00	2.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	1531.05	39.68	6.16	4.62	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	1184.15	66.76	4.79	2.40	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	1590.26	29.82	12.42	7.45	9.94	9.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	1836.91	32.56	7.08	4.72	0.47	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	1565.46	39.83	6.64	6.03	0.60	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	1955.35	38.66	8.65	6.10	0.00	3.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	1669.94	37.49	5.58	7.18	1.20	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	1725.26	39.47	4.44	5.92	1.48	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	2318.39	63.74	11.80	4.72	5.90	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	2002.39	33.26	5.83	4.67	1.75	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	1708.57	29.41	6.14	2.19	0.88	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	1268.15	22.89	6.78	3.39	3.39	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	928.20	54.32	2.98	1.79	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	1047.65	75.70	5.82	4.85	1.46	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	540.98	41.09	2.28	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	478.19	32.02	0.42	1.25	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	947.91	115.82	3.37	2.25	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	612.12	19.66	0.63	0.95	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	733.56	35.51	1.67	1.25	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	749.05	122.54	1.62	1.04	0.12	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	679.76	113.27	0.84	1.18	0.00	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	632.91	105.33	0.46	1.59	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	819.38	124.17	1.20	1.64	0.00	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	636.78	120.14	1.29	0.43	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	601.71	99.25	1.08	0.65	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	863.17	123.29	2.62	1.49	0.25	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	693.06	104.82	1.03	1.37	0.00	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	655.48	113.73	1.92	2.24	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	586.48	77.23	1.68	3.36	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	650.92	71.41	0.00	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	671.53	68.74	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	618.32	93.12	1.41	1.06	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	952.46	38.51	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	590.78	118.37	1.05	1.05	0.00	0.35
Hepatocyte, donor1	11523-119I2	432.19	18.16	3.63	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	522.51	9.70	0.00	0.00	1.08	1.08
Hepatocyte, donor3	11684-122I1	428.25	24.54	0.61	0.61	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	1760.30	154.69	5.87	5.87	1.96	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	1190.09	75.68	0.17	0.17	1.92	1.22
Iris Pigment Epithelial Cells, donor1	11530-119I9	614.27	63.25	0.27	0.55	0.96	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	1120.73	194.22	3.18	0.00	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	887.82	86.78	0.00	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	1381.25	162.50	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	1049.36	134.28	2.77	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	815.87	112.62	2.50	0.00	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	1756.50	94.95	0.00	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	1114.86	125.58	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	1046.71	169.12	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	966.48	118.58	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	1015.39	106.71	5.00	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	838.66	65.35	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	1118.33	117.79	3.97	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	991.13	136.36	2.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	937.65	78.57	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	1402.71	109.60	0.00	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	996.03	126.82	3.09	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	863.45	58.54	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	1313.39	124.69	0.00	1.94	0.65	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	1139.83	132.01	1.61	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	764.68	59.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	1271.21	151.57	4.07	1.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	1177.99	126.36	1.26	0.00	0.84	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	560.52	43.12	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	1400.02	135.02	0.80	3.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	914.97	126.49	0.92	1.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	648.47	45.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	1367.49	115.65	3.30	2.36	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	936.00	145.12	4.53	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	604.44	58.97	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	1337.62	148.50	0.00	3.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	1157.39	177.86	1.27	3.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	903.67	180.73	16.43	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	1066.84	146.03	1.28	3.19	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1224.83	153.10	3.65	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	647.98	31.61	0.00	0.00	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	1270.32	131.39	3.57	4.28	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	1257.64	165.92	3.32	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	792.25	41.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	1213.96	103.40	1.85	0.62	0.31	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	1060.64	138.73	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	1043.52	125.73	0.00	6.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	1195.37	116.83	4.87	2.09	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	1283.60	115.08	4.43	0.00	4.43	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	1124.98	113.47	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	1369.80	76.73	2.62	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	1388.12	157.48	0.00	4.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	860.69	108.02	6.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	1637.50	89.61	3.20	2.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	973.97	134.39	4.16	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	866.28	145.33	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	1372.35	114.13	0.92	1.84	0.92	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	1497.53	96.81	0.00	0.00	3.03	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	788.50	105.55	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	1671.70	86.70	1.06	1.06	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	507.47	42.11	0.41	0.00	2.69	0.24
Keratinocyte - epidermal, donor2	11349-117G8	534.68	39.24	0.00	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	856.35	91.91	1.23	0.66	0.19	0.38
Keratinocyte - oral, donor1	11251-116E9	1324.41	77.53	0.79	0.57	0.57	0.57
Keratocytes, donor1	11527-119I6	822.79	49.17	0.34	0.00	0.34	0.69
Keratocytes, donor2	11607-120I5	769.87	77.34	2.34	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	743.16	26.08	0.40	1.38	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	303.31	21.98	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	639.70	57.17	1.08	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	821.62	14.53	0.23	0.12	0.12	0.23
Lens Epithelial Cells, donor3	11690-122I7	443.40	45.51	0.20	0.50	0.20	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	570.24	46.25	0.95	1.30	2.73	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	921.22	62.51	1.40	2.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	680.18	56.35	0.94	1.26	0.63	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	550.08	60.22	1.08	2.69	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	939.51	69.97	0.63	2.84	1.58	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	760.41	64.47	1.29	0.86	0.22	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	508.89	41.86	0.82	1.64	0.00	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	1112.15	77.62	1.26	1.26	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	683.48	61.09	0.56	1.41	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	548.21	54.58	0.40	1.58	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	944.80	62.82	2.13	0.97	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	906.86	73.13	0.93	1.48	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	557.83	48.08	0.70	2.09	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	956.96	58.92	1.43	1.43	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	746.21	64.69	0.69	0.96	0.82	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	530.30	49.58	0.31	0.92	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	1097.34	77.31	2.18	1.56	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	785.03	73.01	0.91	0.73	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	541.39	44.10	1.32	0.66	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	1037.06	70.29	2.93	2.05	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	899.13	74.68	0.50	1.49	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	534.43	44.13	0.00	3.88	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	965.97	67.32	2.69	2.42	0.54	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	760.52	73.42	0.30	0.76	0.15	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	518.93	51.32	1.56	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	891.38	67.21	1.47	1.47	0.21	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	770.96	69.32	0.90	1.65	0.30	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	575.06	57.09	1.38	1.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	942.62	66.42	0.75	0.94	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	799.57	66.80	0.85	1.06	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	516.56	49.43	1.45	1.45	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	974.50	66.49	0.99	0.66	0.33	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	749.55	61.08	0.99	0.87	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	495.71	45.54	0.37	1.48	1.11	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	936.94	63.25	0.49	0.99	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	780.28	61.60	1.24	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	498.54	52.11	0.64	1.61	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	927.90	55.69	1.83	1.22	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	744.62	67.60	1.12	0.56	0.28	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	531.56	41.96	1.42	1.42	0.00	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	979.25	70.78	2.42	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	883.23	71.74	1.24	1.87	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	630.62	52.64	0.36	0.36	1.07	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	948.34	64.35	1.63	1.63	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	887.31	69.45	1.18	2.59	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	518.52	48.51	0.50	0.25	2.72	1.36
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	1052.94	70.44	1.28	1.79	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	710.69	78.77	1.79	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	1284.83	77.04	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	993.44	74.41	3.07	1.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	796.41	66.80	1.48	0.74	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	1049.78	70.24	4.65	4.65	0.85	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	966.37	68.93	4.92	4.22	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	926.49	86.86	0.93	1.87	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	833.19	51.01	3.61	4.64	1.55	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	1046.72	85.64	3.57	2.38	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	1235.24	65.82	0.00	0.23	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	860.85	58.17	2.62	3.20	0.87	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	840.93	67.53	2.70	2.25	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	1178.59	62.46	1.08	0.95	0.68	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	908.94	75.49	2.57	3.59	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	775.58	60.69	3.18	2.12	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	623.66	72.63	2.67	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	836.41	73.35	4.08	3.06	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	770.53	65.90	2.93	1.60	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	1051.29	58.38	3.02	3.02	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	911.14	72.40	4.91	7.36	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	867.61	70.94	4.89	4.08	0.82	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	982.49	49.35	3.96	2.71	0.42	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	721.95	58.85	4.48	6.73	0.84	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	860.33	66.97	3.09	4.12	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	958.00	48.19	5.81	2.32	0.29	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	807.41	61.28	2.99	2.99	0.30	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	770.69	59.75	3.87	1.66	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	1035.36	54.08	2.83	3.18	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	821.64	67.49	3.69	4.43	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	991.25	81.74	3.45	4.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	1117.87	73.30	3.07	3.45	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	939.78	58.88	6.79	7.93	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	886.11	79.59	1.64	1.64	0.82	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	1184.39	64.17	3.16	5.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	920.66	71.10	6.46	2.87	0.00	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	1010.56	65.73	3.73	1.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	981.75	59.08	3.72	2.23	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	750.79	75.38	0.86	3.45	0.43	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	887.98	84.77	3.43	2.57	0.00	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	1212.43	70.97	3.33	5.66	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	841.01	66.97	4.22	3.02	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	960.56	68.97	4.27	2.13	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	1172.08	57.40	3.78	3.09	0.00	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	841.62	66.02	4.83	1.61	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	952.13	68.01	2.69	2.02	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	1120.48	58.89	3.33	3.33	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	1457.15	70.94	2.33	3.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	927.64	70.87	1.06	4.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	1082.01	64.02	1.60	2.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	870.07	68.33	1.45	2.18	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	1143.64	68.99	3.07	3.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	1239.61	67.58	4.93	3.45	0.00	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	844.96	57.40	0.00	3.76	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	1035.31	68.89	1.51	3.02	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	1107.63	57.23	4.06	3.15	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	683.28	61.96	3.44	6.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	1059.03	61.46	4.45	5.34	0.45	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	1110.12	51.22	3.52	6.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	849.08	58.06	1.98	3.96	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	1089.74	77.84	2.59	3.11	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	972.71	67.39	3.50	5.25	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	740.81	62.06	2.80	2.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	944.23	66.25	2.65	1.77	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	1172.57	64.03	3.09	3.09	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	738.77	51.14	4.56	3.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	891.55	55.27	1.44	1.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	1011.36	58.04	3.18	5.96	0.00	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	713.35	51.04	4.25	2.43	0.00	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	594.17	60.87	3.46	0.00	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	1130.47	67.26	3.42	3.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	828.85	64.55	4.65	5.68	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	618.56	60.47	2.42	4.23	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	1098.38	63.70	1.58	2.54	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	888.66	75.17	2.13	3.20	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	643.06	63.79	1.72	2.87	1.72	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	1148.80	66.34	6.17	2.06	0.00	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	872.87	71.44	1.41	3.54	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	671.90	67.53	2.84	2.84	1.70	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	1095.81	57.41	1.66	2.91	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	891.88	73.61	5.48	3.13	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	725.70	68.48	2.51	3.34	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	1249.87	72.95	0.93	4.65	0.46	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	970.12	68.91	2.68	6.02	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	742.08	70.57	1.07	1.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	1187.64	78.80	5.66	4.04	0.00	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	902.16	69.75	3.67	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	608.15	56.01	0.89	5.33	0.00	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	1413.85	83.20	2.85	1.14	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	927.18	81.29	0.77	4.60	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	615.57	75.51	1.64	2.74	2.19	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	1048.14	71.27	3.12	1.78	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	1276.12	77.47	1.82	0.52	0.26	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	788.43	76.26	6.63	1.99	0.00	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	1469.58	83.14	6.24	2.08	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	287.40	12.76	0.00	0.23	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	256.91	22.20	0.00	0.37	0.55	0.00
Macrophage - monocyte derived, donor3	11389-118C3	333.73	22.28	0.52	0.26	0.00	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	704.13	115.76	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	370.78	29.63	0.00	0.16	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	518.01	88.95	0.42	0.14	0.28	0.14
Mammary Epithelial Cell, donor1	11273-116H4	608.92	45.24	0.10	0.30	0.40	0.10
Mammary Epithelial Cell, donor2	11350-117G9	543.48	52.12	0.58	0.87	0.87	0.29
Mammary Epithelial Cell, donor3	11422-118F9	758.26	51.38	1.00	0.50	0.50	0.50
Mast cell - stimulated, donor1	11487-119E2	420.32	22.37	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	343.46	14.60	0.54	0.00	0.00	0.00
Mast cell, donor2	11565-120D8	787.21	9.81	1.49	0.30	0.00	0.30
Mast cell, donor3	11566-120D9	708.92	14.86	1.13	0.68	1.58	0.90
Mast cell, donor4	11567-120E1	790.89	8.51	2.30	0.53	0.35	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	321.03	22.62	0.22	0.33	1.22	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	461.69	30.35	0.58	0.00	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	378.58	11.47	0.23	0.23	0.92	0.57
Mast cell, expanded, donor8	11941-126A6	558.67	15.40	1.34	0.67	1.34	0.50
Melanocyte - dark, donor1	11502-119F8	910.70	101.79	0.30	0.30	0.60	0.40
Melanocyte - dark, donor2	11582-120F7	770.38	64.37	1.38	1.73	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	558.88	64.40	0.22	0.14	0.14	0.07
Melanocyte - light, donor1	11274-116H5	357.78	17.87	1.18	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	507.07	28.66	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	631.34	20.81	2.60	2.60	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	712.63	33.63	2.08	0.83	0.21	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	853.35	58.09	0.81	1.08	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	491.51	19.55	0.54	0.27	0.27	0.27
Meningeal Cells, donor1	11493-119E8	423.42	47.64	0.12	0.12	0.25	0.12
Meningeal Cells, donor2	11573-120E7	606.52	58.10	1.32	0.00	0.00	0.44
Meningeal Cells, donor3	11654-122E7	703.85	78.16	0.24	0.49	0.16	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	800.15	87.54	0.57	0.29	0.00	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	453.05	26.97	0.20	0.60	0.60	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1420.61	26.28	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	965.42	71.95	2.62	0.00	1.31	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	1081.43	86.11	1.44	2.15	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	394.95	18.00	0.42	0.42	1.91	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	292.54	30.66	0.00	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	752.65	129.00	0.44	0.22	1.54	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	844.56	119.82	2.19	2.19	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	712.43	103.73	0.61	1.23	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	464.97	23.13	0.28	0.28	2.91	1.11
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	902.92	39.03	0.37	0.37	1.86	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	1135.35	27.89	0.26	0.92	1.71	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	1023.16	26.11	1.19	0.30	0.89	1.19
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	847.80	23.36	0.00	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	984.94	101.18	1.92	1.28	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	935.02	101.37	0.35	0.00	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	1182.72	30.96	0.31	0.31	0.94	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	986.94	150.22	0.73	1.45	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	301.77	27.05	0.53	0.27	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	446.42	44.54	0.00	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	324.18	17.63	0.51	0.29	0.07	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	143.13	10.80	0.00	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	380.99	22.66	0.74	1.48	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	335.39	15.31	0.29	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	117.54	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	357.68	16.74	0.93	0.31	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	295.80	18.88	0.41	0.00	0.21	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	97.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	359.88	12.76	0.50	1.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	323.51	18.62	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	339.57	15.85	0.81	1.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	315.98	13.86	0.40	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	68.41	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	402.65	16.81	0.88	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	426.67	23.56	1.52	0.38	0.38	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	117.12	3.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	331.49	17.19	0.64	0.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	179.56	9.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	240.23	8.94	1.19	0.89	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	122.40	5.03	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	387.14	15.31	1.76	1.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	268.33	16.16	0.00	0.24	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	150.94	4.98	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	256.03	19.34	0.69	0.46	0.23	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	255.35	13.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	223.60	8.76	0.41	0.61	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	295.42	17.81	0.64	1.07	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	228.96	12.23	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	51.59	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	217.70	14.24	0.44	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	150.06	11.15	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	130.90	6.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	234.01	17.94	1.09	0.54	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	265.85	13.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	104.67	6.54	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	357.53	27.39	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	254.95	18.01	0.40	0.80	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	112.44	6.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	371.43	30.54	0.00	1.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	404.21	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	93.77	10.19	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	338.08	36.79	1.75	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	109.26	12.14	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	117.19	8.33	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	293.54	36.20	0.50	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	119.69	11.13	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	70.72	13.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	221.19	19.83	1.71	0.00	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	120.34	11.38	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	129.61	9.23	0.00	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	271.85	33.11	0.56	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	160.43	19.12	1.25	0.42	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	87.41	5.83	0.00	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	130.02	12.97	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	176.14	25.88	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	86.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	144.07	14.78	1.85	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	176.43	26.18	0.57	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	142.47	9.95	0.14	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	173.89	23.32	0.00	0.78	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	138.13	17.59	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	71.14	3.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	128.11	15.21	0.80	0.53	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	167.62	17.36	0.30	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	113.57	6.78	0.42	0.14	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	205.76	18.47	0.64	0.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	206.09	30.52	0.00	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	109.97	9.10	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	163.65	22.16	0.00	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	212.13	27.53	0.25	0.49	0.49	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	89.28	4.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	132.02	14.41	0.00	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	190.01	15.57	0.29	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	122.82	7.83	0.41	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	134.00	14.89	0.30	0.30	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	670.50	15.07	0.00	7.53	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	573.88	10.69	1.78	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	463.61	17.09	0.33	0.99	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	500.73	24.19	2.10	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	476.42	5.73	0.40	0.00	2.77	1.58
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	482.42	3.73	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	486.69	23.66	1.13	0.38	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	415.76	27.97	1.60	0.53	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	360.45	8.37	0.11	0.34	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	445.72	5.89	3.68	2.21	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	395.37	13.92	1.10	1.10	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	346.90	17.11	3.11	4.67	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	479.39	11.22	0.00	1.07	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	548.67	19.32	0.00	3.86	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	570.62	19.19	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	440.61	30.36	0.42	2.53	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	646.92	19.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1251.88	21.62	0.00	0.64	0.64	1.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1324.08	34.82	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	601.15	19.64	0.00	3.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	491.07	0.00	0.00	0.00	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	619.87	16.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	270.89	33.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	426.67	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	408.47	45.24	0.22	0.22	0.86	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	440.56	19.86	1.57	0.00	1.05	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	222.94	25.36	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	322.21	16.28	0.42	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	591.53	37.65	2.09	2.66	0.00	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	478.76	51.07	0.00	0.00	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	196.50	8.16	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	227.87	14.70	0.00	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	239.40	12.56	1.26	1.67	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	435.12	28.59	0.70	1.39	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	377.24	15.13	1.62	0.81	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	313.46	15.14	0.42	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	244.96	0.00	0.00	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	378.72	14.39	1.49	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	397.88	12.18	1.35	0.27	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	419.59	10.43	1.13	1.36	0.00	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	389.96	8.49	0.49	1.14	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	409.34	14.76	1.09	0.55	0.18	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	352.74	9.55	1.59	1.59	0.00	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	317.56	5.40	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	467.98	13.13	0.98	2.63	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	422.50	6.34	0.65	0.65	0.16	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	364.93	13.23	0.18	0.71	0.53	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	445.85	10.55	0.70	1.41	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	485.91	6.90	0.46	0.46	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	530.22	16.07	1.93	2.57	0.00	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	562.17	12.42	3.10	3.10	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	326.17	5.06	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	381.41	12.25	0.45	0.22	0.45	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	436.09	11.01	1.27	0.42	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	397.09	7.83	0.71	1.19	0.00	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	652.03	16.31	1.29	1.29	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	306.94	9.03	0.00	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	500.17	9.33	1.33	1.00	0.33	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	339.95	14.88	0.00	0.90	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	366.25	12.30	0.00	2.38	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	439.25	9.29	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	693.56	14.38	1.89	1.14	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	312.85	11.41	0.33	0.00	0.00	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	470.65	6.97	0.44	0.00	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	344.64	16.73	0.45	1.36	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	373.05	22.05	0.00	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	444.12	12.63	2.66	3.32	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	446.94	13.89	0.50	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	336.50	7.27	0.00	1.15	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	830.21	9.98	0.91	1.51	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	329.33	14.59	0.88	0.88	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	426.25	14.23	0.68	3.39	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	224.82	10.22	0.00	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	538.96	7.32	3.66	0.00	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	413.56	8.50	0.00	0.63	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	634.66	6.66	1.21	1.51	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	445.41	6.33	1.58	1.58	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	494.27	6.80	4.53	3.40	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	288.30	0.00	0.00	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	457.91	50.19	0.50	0.62	0.25	0.50
Myoblast, donor2	11322-117D8	579.39	39.12	0.38	0.58	0.19	0.19
Myoblast, donor3	11398-118D3	424.11	47.59	0.84	0.17	1.01	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	1152.14	69.76	1.17	1.02	1.17	0.73
Natural Killer Cells, donor1	11230-116C6	1466.24	37.82	1.23	0.62	1.23	1.23
Natural Killer Cells, donor2	11311-117C6	1745.11	59.41	5.73	5.13	1.81	1.51
Natural Killer Cells, donor3	11387-118C1	1290.03	39.20	2.39	0.92	0.55	0.74
Neural stem cells, donor1	11275-116H6	331.00	44.28	0.36	0.36	0.73	0.00
Neural stem cells, donor2	11352-117H2	200.27	28.88	0.00	0.00	0.00	1.93
Neurons, donor1	11494-119E9	712.32	64.86	1.14	1.14	4.55	6.83
Neurons, donor2	11574-120E8	573.97	28.62	0.66	0.22	0.22	0.00
Neurons, donor3	11655-122E8	762.97	41.93	1.64	3.29	6.58	2.47
Neutrophils, donor1	11233-116C9	77.02	1.86	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	75.37	0.00	0.00	0.00	0.00	2.90
Neutrophils, donor3	11390-118C4	84.30	2.44	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	860.48	24.82	0.47	0.36	0.83	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	930.90	17.26	0.65	0.65	0.33	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	694.71	32.09	1.40	2.41	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	577.31	13.90	0.55	1.79	0.55	0.55
Olfactory epithelial cells, donor2	11934-125I8	617.63	22.58	2.03	1.59	0.72	0.58
Olfactory epithelial cells, donor3	11935-125I9	696.47	14.19	0.45	0.91	0.11	0.34
Olfactory epithelial cells, donor4	11936-126A1	754.93	15.29	0.88	2.73	0.58	0.88
Oligodendrocyte - precursors, donor1	11496-119F2	744.45	46.94	0.00	0.00	0.60	1.20
Osteoblast - differentiated, donor1	11276-116H7	608.94	19.14	1.49	0.85	0.43	0.43
Osteoblast - differentiated, donor2	11353-117H3	748.74	22.86	2.29	4.57	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	2140.21	29.79	4.97	2.48	0.00	1.86
Osteoblast, donor1	11277-116H8	1027.61	85.41	0.39	1.17	0.39	0.39
Osteoblast, donor2	11354-117H4	406.64	66.72	0.70	0.70	2.11	0.70
Osteoblast, donor3	11426-118G4	703.63	60.78	1.24	0.53	0.18	0.36
Pancreatic stromal cells, donor1	11249-116E7	643.64	34.71	0.67	0.42	0.67	1.01
Pericytes, donor1	11491-119E6	523.62	7.68	0.22	0.45	2.45	1.22
Pericytes, donor2	11571-120E5	716.45	24.45	1.58	2.49	0.00	0.45
Pericytes, donor3	11652-122E5	889.89	70.60	2.85	2.24	0.20	0.20
Perineurial Cells, donor1	11499-119F5	721.98	60.92	0.11	0.23	0.23	0.23
Perineurial Cells, donor2	11579-120F4	889.56	55.67	0.18	0.28	0.37	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	1129.29	24.54	0.64	0.64	0.64	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	1168.73	18.36	3.18	1.96	0.73	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	1018.11	32.74	3.49	1.55	0.39	0.13
Placental Epithelial Cells, donor1	11278-116H9	1086.77	100.21	2.63	0.96	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	1003.54	85.38	3.33	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	1262.58	51.24	3.93	1.18	0.00	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	437.97	28.80	3.48	1.90	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	371.24	17.82	0.94	0.00	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	133.79	11.49	0.00	0.00	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	543.73	22.29	1.80	2.48	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	351.43	17.58	0.64	0.43	1.70	0.32
Preadipocyte - omental, donor2	11329-117E6	281.09	16.59	1.31	0.44	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	351.82	35.38	0.43	1.00	0.00	0.29
Preadipocyte - perirenal, donor1	11469-119C2	406.50	28.54	2.95	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	551.89	67.87	0.00	0.31	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	655.01	95.98	1.59	1.42	0.35	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	789.95	72.54	3.58	2.72	0.34	0.51
Preadipocyte - visceral, donor1	11280-116I2	489.58	71.82	0.47	0.28	1.30	0.00
Preadipocyte - visceral, donor2	11357-117H7	397.14	38.66	1.38	1.84	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	457.77	72.52	3.13	2.09	0.10	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	1536.13	95.79	5.43	0.75	1.81	2.87
Prostate Epithelial Cells, donor2	11331-117E8	344.36	38.32	1.62	0.81	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	932.09	39.25	3.49	1.41	0.18	0.18
Prostate Stromal Cells, donor1	11254-116F3	711.19	72.21	0.57	0.34	0.57	0.57
Prostate Stromal Cells, donor2	11332-117E9	693.53	59.89	2.69	1.97	0.00	0.18
Prostate Stromal Cells, donor3	11405-118E1	602.09	20.65	2.92	0.83	0.21	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	826.32	54.75	0.36	0.73	1.82	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	666.50	30.98	0.28	0.21	0.49	0.14
Renal Epithelial Cells, donor1	11517-119H5	894.76	95.36	1.01	0.51	0.51	0.51
Renal Epithelial Cells, donor2	11597-120H4	779.61	73.98	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	742.75	31.34	0.21	0.42	0.42	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	546.72	71.49	2.04	1.36	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	568.71	94.33	2.16	0.54	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	517.29	97.91	1.11	3.33	0.44	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	556.31	49.24	2.66	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	685.79	68.23	0.66	0.22	0.88	0.44
Renal Mesangial Cells, donor2	11598-120H5	840.79	65.83	0.00	3.13	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	861.64	42.44	1.39	0.83	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	753.46	84.02	0.54	0.27	0.81	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	730.79	50.18	1.27	1.27	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	920.27	93.53	1.74	0.77	0.39	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	814.14	54.19	0.52	0.78	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	808.39	44.06	0.85	0.57	0.00	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	801.69	97.77	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	746.45	38.14	0.00	0.25	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	811.97	14.30	1.20	0.40	0.27	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	426.15	71.47	0.89	0.89	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	392.41	111.73	0.00	0.55	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	314.39	62.65	0.00	0.58	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	329.22	103.11	0.91	0.13	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	544.89	139.42	0.60	1.19	0.10	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	636.11	168.76	0.33	0.78	1.00	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	438.00	115.36	0.99	0.37	0.25	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	585.87	152.32	0.82	0.93	0.23	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	679.99	167.34	0.23	2.31	0.23	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	303.66	129.10	0.55	0.00	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	540.20	144.31	1.36	1.21	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	686.48	173.46	0.36	0.72	0.90	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	341.14	134.13	0.43	0.72	0.43	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	572.74	146.05	0.86	0.43	0.00	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	710.50	187.86	0.89	0.66	0.66	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	245.09	131.15	0.76	0.00	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	483.42	143.28	0.56	0.65	0.47	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	496.26	142.62	0.00	0.00	0.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	336.28	122.89	0.66	0.13	0.13	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	476.87	155.75	1.27	0.49	0.10	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	601.14	164.03	0.38	0.00	0.95	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	324.12	120.68	0.64	0.64	0.21	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	505.67	143.24	1.12	0.56	1.40	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	533.20	162.35	0.68	0.68	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	328.19	120.16	0.36	0.91	0.36	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	505.49	148.51	1.35	0.37	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	678.18	177.97	1.21	0.54	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	276.68	156.62	0.71	0.94	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	554.96	140.68	0.79	0.79	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	686.81	186.61	1.40	1.17	1.17	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	355.82	162.36	0.41	0.62	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	520.29	154.18	4.20	2.65	1.33	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	601.80	164.81	0.42	0.42	0.42	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	333.23	139.70	0.00	0.94	0.27	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	462.01	158.20	0.51	0.17	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	534.43	145.37	0.19	0.77	0.96	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	264.10	143.05	0.52	0.69	0.17	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	500.12	157.47	0.14	1.10	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	608.08	157.60	1.97	1.15	0.66	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	265.87	118.79	0.34	0.34	0.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	515.93	164.08	0.59	0.74	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	429.68	119.68	0.00	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	374.70	62.63	0.41	0.69	0.00	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	687.88	121.67	1.67	0.48	0.24	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	482.69	93.31	0.20	0.40	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	381.59	64.98	1.04	0.47	0.00	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	732.61	89.44	0.35	1.05	1.75	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	554.26	81.90	0.60	1.51	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	354.55	82.73	0.61	0.86	0.12	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	517.44	68.99	0.58	0.29	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	831.72	91.26	1.22	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	380.97	97.95	0.60	0.60	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	567.96	80.30	1.36	0.68	0.23	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	499.63	54.52	0.30	0.30	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	381.50	66.12	0.83	0.94	0.35	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	614.08	77.91	1.07	1.28	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	406.26	47.48	0.00	0.60	1.20	0.00
Schwann Cells, donor1	11498-119F4	857.23	75.79	1.13	0.75	0.19	0.56
Schwann Cells, donor2	11578-120F3	653.26	51.04	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	514.84	68.57	0.44	1.53	0.22	0.00
Sebocyte, donor1	11220-116B5	522.02	49.30	0.55	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	514.70	41.82	1.38	4.14	0.00	0.00
Sebocyte, donor3	11378-118B1	818.06	42.46	1.24	1.86	0.21	0.41
Sertoli Cells, donor1	11255-116F4	564.90	61.29	1.66	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	725.86	19.77	5.65	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	1269.61	76.89	1.58	0.88	1.41	0.18
Skeletal Muscle Cells, donor2	11358-117H8	899.94	44.09	2.17	5.78	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	919.64	126.24	2.51	2.51	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	770.23	111.54	2.67	2.51	0.31	0.79
Skeletal Muscle Cells, donor5	11455-119A6	714.09	102.42	2.82	2.68	0.59	0.89
Skeletal Muscle Cells, donor6	11459-119B1	768.74	99.88	2.62	1.85	0.00	1.39
Skeletal Muscle Satellite Cells, donor1	11240-116D7	1034.76	54.31	1.26	0.38	1.39	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	910.64	52.51	2.14	1.28	0.00	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	863.03	91.67	1.29	1.88	0.30	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	789.78	50.72	0.17	0.59	0.42	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	955.37	92.64	0.00	1.45	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	514.21	33.99	2.20	3.03	0.14	0.41
Skin - palm, donor1	10286-104F7	327.71	21.49	0.00	0.00	2.69	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	547.51	85.05	3.17	2.16	0.00	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	96.51	72.79	1.64	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	509.44	64.39	2.34	1.43	0.00	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	716.72	58.80	1.67	0.56	0.28	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	441.94	50.36	0.56	0.84	0.14	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	303.85	42.08	0.00	0.21	0.21	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	599.60	37.33	0.97	0.75	0.07	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	488.49	58.01	4.01	0.93	0.00	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	114.95	13.56	0.44	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	633.68	41.15	0.00	1.76	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	367.73	30.94	0.44	0.22	0.44	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	708.02	77.57	0.39	1.18	0.00	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	620.37	50.22	0.77	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	1081.82	4.00	2.00	3.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	564.91	45.51	0.27	0.67	0.40	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	636.37	69.82	2.22	0.89	0.00	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	548.99	69.26	2.69	3.84	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	592.90	42.00	0.33	0.98	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	525.09	51.39	0.00	0.59	0.89	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	513.51	42.85	1.14	1.14	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	726.34	81.34	0.16	0.65	0.65	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	395.46	25.88	1.22	3.04	0.00	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	755.16	52.28	1.01	0.76	0.00	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	281.55	24.48	0.00	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	603.68	49.59	1.43	3.81	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	714.22	41.00	0.44	0.29	0.29	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	639.47	48.43	1.94	1.72	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	741.95	64.97	1.99	0.52	0.10	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	745.55	66.05	0.46	0.62	0.15	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	545.41	83.00	3.23	2.16	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	455.76	40.94	2.69	2.39	0.60	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	861.69	124.61	0.68	1.02	0.68	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	1082.05	31.80	0.31	0.31	0.24	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	378.61	35.22	0.91	0.40	1.91	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	431.90	45.51	0.91	1.82	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	483.65	64.00	0.00	3.62	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	867.63	126.90	0.79	1.06	1.06	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	326.24	43.01	0.93	0.00	2.00	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	597.42	47.96	2.25	2.38	0.25	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	624.77	11.92	0.76	0.76	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	534.19	53.68	0.30	0.60	0.45	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	693.15	25.51	1.50	1.50	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	339.85	31.01	5.17	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	649.70	53.02	0.93	0.00	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	712.39	75.73	3.53	1.51	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	303.05	43.56	1.88	3.13	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	478.78	57.23	0.00	0.59	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	811.99	122.46	0.33	0.33	0.25	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	647.48	22.89	1.87	1.87	0.47	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	562.29	44.04	0.29	0.72	0.14	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	939.26	81.59	1.53	1.27	0.00	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	611.11	73.90	1.69	1.50	0.00	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	735.47	68.61	0.14	0.42	0.28	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	964.57	49.60	0.34	0.59	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	818.08	26.19	0.95	0.95	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	568.35	37.19	0.49	0.24	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	360.59	34.47	0.66	1.10	1.55	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	707.16	46.23	0.88	0.59	0.88	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	435.76	8.36	0.39	0.19	0.00	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	243.30	23.27	0.53	2.12	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	285.66	19.71	0.74	2.60	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	314.78	29.11	0.36	0.72	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	217.75	35.77	0.00	1.70	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	407.65	63.02	1.97	1.58	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	340.04	21.59	2.54	1.02	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	361.78	6.79	2.40	0.80	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	507.46	16.30	5.02	2.93	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	524.36	16.50	1.38	0.46	0.00	1.38
Synoviocyte, donor1	11291-117A4	538.96	23.23	0.50	0.34	3.20	0.67
Synoviocyte, donor2	11368-117I9	721.29	14.75	2.18	1.68	0.17	0.84
Synoviocyte, donor3	11440-118H9	699.94	7.37	3.35	3.57	0.45	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	789.70	90.05	1.07	0.71	1.79	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	703.62	23.78	3.96	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	787.95	57.66	1.16	0.69	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	674.05	43.08	0.29	0.65	0.57	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	899.53	65.72	0.39	2.71	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	616.76	48.68	1.15	2.29	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	731.01	17.10	1.35	0.86	0.49	0.37
Urethra, donor2	10319-105A4	300.34	7.19	0.00	1.80	1.80	0.00
Urothelial Cells, donor1	11520-119H8	545.93	41.18	0.80	0.80	1.06	0.53
Urothelial Cells, donor2	11600-120H7	745.45	22.43	3.20	1.60	0.00	0.00
Urothelial Cells, donor3	11681-122H7	873.73	27.73	1.15	0.92	0.23	0.23
Urothelial cells, donor0	11216-116B1	736.00	18.95	0.22	0.00	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	411.08	6.23	0.00	1.78	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	476.06	2.86	0.00	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	440.15	10.27	1.37	1.37	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	728.96	15.84	0.69	0.00	7.58	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	720.47	14.53	0.58	1.16	2.91	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	366.52	9.37	0.00	1.04	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	390.06	12.85	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	646.33	17.35	0.91	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	870.93	75.99	2.59	0.86	0.49	1.23
Wilms' tumor cell line:HFWT	10597-108E3	609.87	46.64	0.88	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	859.18	69.83	1.12	2.23	0.28	0.00
achilles tendon, donor2	10292-104G4	320.31	2.07	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	1666.90	314.11	1.02	2.04	11.47	2.80
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	1435.30	97.98	0.00	0.93	0.93	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	1081.07	41.55	0.24	1.19	1.78	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	782.60	198.10	0.54	0.54	5.17	1.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	714.23	190.86	1.97	1.69	0.56	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	1321.97	141.90	1.06	1.27	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	1415.77	101.53	2.45	2.18	0.82	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	1601.28	153.34	2.20	2.20	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	844.08	98.82	2.04	1.23	0.82	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	1517.47	144.84	3.11	1.94	1.16	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	992.31	142.42	2.76	1.66	0.00	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	1072.64	128.72	3.90	11.70	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	915.58	133.62	2.79	2.09	0.00	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	1804.54	200.13	1.55	2.59	0.78	2.85
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	1087.73	120.70	2.63	1.75	0.88	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	650.20	66.00	0.00	1.39	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	1130.95	145.99	0.00	3.70	1.23	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	528.26	32.54	1.23	0.61	0.00	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	937.48	74.25	0.43	0.43	1.71	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	916.55	62.78	0.00	0.00	0.91	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	947.18	80.40	0.24	0.00	0.72	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	639.48	200.02	1.56	0.45	0.22	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	894.57	155.10	1.67	1.00	0.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	1137.22	215.55	3.72	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	1135.25	319.78	2.26	4.90	0.38	1.88
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	549.53	126.04	0.44	0.87	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	1074.07	279.30	0.00	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	836.26	34.85	0.47	2.12	0.71	0.47
adipose tissue, adult, pool1	10010-101C1	517.17	9.93	0.31	0.47	0.00	0.00
adipose, donor1	10184-103D4	1555.74	35.77	9.97	8.21	0.00	1.17
adipose, donor2	10185-103D5	1264.00	24.33	4.46	2.43	1.22	0.41
adipose, donor3	10186-103D6	811.15	44.11	5.99	4.08	0.54	0.27
adipose, donor4	10187-103D7	905.76	33.80	2.60	1.73	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	955.28	124.36	1.58	1.26	0.47	0.63
adrenal gland, adult, pool1	10081-102A9	421.97	10.91	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	861.14	36.02	0.27	0.53	0.67	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	845.37	33.23	2.14	0.71	0.71	1.43
amniotic membrane cells, donor1	12235-129G3	635.73	13.91	0.00	0.00	0.23	0.70
amniotic membrane cells, donor2	12236-129G4	879.07	18.93	1.01	0.34	0.00	0.68
amniotic membrane cells, donor3	12237-129G5	505.24	11.49	0.88	0.88	0.59	0.88
amygdala - adult, donor10196	10167-103B5	125.69	20.16	0.00	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	245.96	7.71	0.00	0.41	0.41	0.20
amygdala, newborn, donor10223	10360-105E9	172.04	14.20	0.65	0.00	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	985.79	28.27	0.89	0.89	0.51	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	1957.59	268.72	4.19	4.63	1.76	2.21
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	907.58	38.08	1.00	1.00	1.34	1.00
aorta, adult, pool1	10052-101G7	626.45	10.00	1.18	0.39	0.39	0.59
appendix, adult	10189-103D9	996.30	28.72	3.10	2.33	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	974.37	76.70	1.38	0.34	0.34	0.34
artery, adult	10190-103E1	1108.69	6.79	4.08	2.72	4.08	0.00
astrocytoma cell line:TM-31	10425-106D2	987.41	84.89	0.58	0.87	0.43	0.14
b cell line:RPMI1788	10427-106D4	1207.60	52.64	0.45	0.15	1.04	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	382.32	35.24	0.55	0.55	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	694.52	53.68	0.50	0.10	0.40	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	1107.04	115.66	1.00	0.50	2.51	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	2146.35	73.82	2.80	2.80	1.68	1.68
bladder, adult, pool1	10011-101C2	842.30	12.17	1.30	2.39	2.17	0.54
blood, adult, pool1	10053-101G8	992.15	6.64	0.00	4.43	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	232.93	46.24	0.86	0.86	0.86	0.86
bone marrow, adult	10192-103E3	494.65	38.47	0.67	1.35	1.35	0.67
brain, adult, donor1	10084-102B3	329.05	5.13	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	303.45	9.24	0.45	0.45	0.33	0.00
brain, fetal, pool1	10085-102B4	1020.47	32.06	2.67	2.67	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	788.25	28.08	1.98	2.97	0.66	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	494.67	14.73	0.25	0.37	0.62	0.00
breast, adult, donor1	10080-102A8	608.63	5.05	1.26	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	808.21	76.22	0.89	1.91	0.64	1.40
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	645.34	43.29	1.24	0.31	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	1212.10	78.73	3.45	1.15	0.23	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	778.79	126.85	1.94	0.97	0.48	0.97
carcinoid cell line:NCI-H1770	10703-109H1	1326.34	29.62	2.35	1.41	0.47	2.35
carcinoid cell line:NCI-H727	10735-110B6	476.79	31.39	0.22	0.11	0.00	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	1182.66	104.89	2.85	3.17	1.58	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	1128.33	40.99	1.60	1.86	1.60	0.53
caudate nucleus - adult, donor10196	10177-103C6	210.69	12.66	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	291.98	7.03	0.33	0.67	0.33	0.33
caudate nucleus, adult, donor10258	10379-105H1	381.31	19.87	0.00	1.53	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	271.38	17.95	1.46	1.10	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	198.10	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	215.22	2.78	0.21	0.21	0.21	1.28
cerebellum, adult, pool1	10083-102B2	437.39	8.28	0.34	0.34	0.69	0.69
cerebellum, newborn, donor10223	10357-105E6	327.13	15.78	0.83	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	383.76	11.35	0.00	0.76	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	284.31	11.69	0.73	4.39	3.65	0.00
cervical cancer cell line:D98-AH2	10552-107I3	1019.42	131.85	0.29	0.72	1.29	0.14
cervical cancer cell line:ME-180	10553-107I4	1306.01	113.52	0.33	1.16	1.66	0.50
cervix, adult, pool1	10013-101C4	964.54	16.17	0.84	0.84	1.68	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	963.94	39.29	0.56	0.84	0.70	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	252.11	16.98	0.00	1.31	1.31	1.31
choriocarcinoma cell line:BeWo	10423-106C9	1767.70	80.53	5.97	1.12	0.50	0.12
choriocarcinoma cell line:SCH	10785-110H2	2050.25	125.06	4.31	2.09	0.86	1.11
choriocarcinoma cell line:T3M-3	10618-108G6	759.68	41.03	0.95	1.19	0.71	0.24
chorionic membrane cells, donor1	12238-129G6	878.41	19.37	0.57	0.57	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	772.18	27.94	1.19	0.50	0.30	0.20
chorionic membrane cells, donor3	12240-129G8	689.05	14.84	1.10	3.30	1.10	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	923.97	287.79	12.12	6.06	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	1367.74	250.88	2.31	3.07	2.31	2.11
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	1005.88	120.80	1.27	1.27	0.84	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	696.19	64.71	0.26	0.26	0.26	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	692.01	64.10	0.73	0.24	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	628.34	69.02	0.61	0.41	0.81	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	1060.33	146.34	0.59	0.88	3.24	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	1168.12	142.04	0.52	0.78	1.82	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	788.61	87.09	5.26	2.74	0.69	0.46
clear cell carcinoma cell line:TEN	10636-108I6	1227.90	52.40	1.04	1.21	3.82	0.69
colon carcinoma cell line:CACO-2	10513-107D9	891.05	139.84	0.00	0.55	1.10	0.37
colon carcinoma cell line:COLO-320	10420-106C6	1308.24	33.07	0.76	0.38	1.14	0.76
colon, adult, donor1	10082-102B1	968.69	17.85	0.00	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	857.54	19.74	1.29	0.59	1.06	0.47
colon, fetal, donor1	10070-101I7	755.18	12.98	2.47	0.62	0.62	0.62
common myeloid progenitor CMP, donor1	12130-128D6	440.02	45.84	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	4030.91	225.33	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	825.64	56.52	0.85	0.42	2.55	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	773.07	89.65	0.60	0.45	1.66	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	844.38	97.72	0.42	0.56	0.99	0.14
corpus callosum, adult, pool1	10042-101F6	425.11	6.74	0.00	0.22	1.00	0.22
cruciate ligament, donor2	10295-104G7	351.74	25.94	2.43	0.81	4.86	0.81
diaphragm, fetal, donor1	10069-101I6	989.56	24.08	5.62	4.82	0.00	1.61
diencephalon, adult	10193-103E4	233.99	11.52	1.20	0.48	0.72	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	1784.54	235.58	5.05	6.89	0.23	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	744.44	75.65	0.26	0.26	0.26	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	933.76	59.70	0.24	0.96	2.65	0.48
ductus deferens, adult	10196-103E7	527.24	15.45	0.50	4.49	1.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	947.67	25.92	2.88	2.88	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	760.66	43.40	4.41	2.94	0.74	0.74
dura mater, adult, donor1	10041-101F5	632.21	25.27	0.25	0.17	0.50	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	1155.67	91.49	2.22	1.33	1.55	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	1148.21	139.14	0.57	0.57	1.00	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	1355.94	70.29	1.23	1.23	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	1422.74	59.63	3.94	2.72	0.30	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	1686.08	80.89	1.54	3.09	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	981.16	69.61	3.94	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	1760.78	219.89	1.34	1.68	4.02	2.35
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	2037.63	104.21	2.72	1.81	7.61	2.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	802.30	71.40	2.09	3.06	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	549.23	47.02	0.33	0.22	0.33	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	758.57	95.25	0.55	0.66	0.66	0.00
epididymis, adult	10197-103E8	528.30	14.86	0.63	2.51	0.21	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	452.04	34.77	0.18	0.53	3.02	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	773.51	41.29	0.79	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	1113.66	93.83	1.05	1.05	0.66	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	949.26	73.82	1.48	0.98	0.10	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	1071.56	95.45	1.12	1.01	0.34	0.67
esophagus, adult, pool1	10015-101C6	856.33	20.60	1.91	1.17	0.53	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	1665.26	76.27	1.00	0.75	1.38	0.63
eye - muscle inferior rectus, donor1	10272-104E2	231.80	21.73	2.41	2.41	0.00	4.83
eye - muscle lateral, donor2	10298-104H1	239.88	18.94	0.00	4.21	0.00	2.10
eye - muscle medial, donor2	10299-104H2	136.92	10.42	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	268.28	10.32	0.00	1.15	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	323.54	21.86	0.00	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	792.45	11.95	1.27	1.78	0.25	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	771.40	77.83	1.67	0.64	0.90	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	671.66	73.60	1.42	1.42	0.24	0.47
frontal lobe, adult, pool1	10040-101F4	206.79	8.07	0.19	0.09	0.28	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	445.27	88.57	0.90	0.90	5.40	1.80
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	844.14	55.32	0.46	0.46	1.01	0.37
gall bladder, adult	10198-103E9	649.21	26.80	1.93	1.93	0.00	0.00
gamma delta positive T cells, donor1	11937-126A2	1923.55	25.77	2.15	0.54	3.22	0.54
gamma delta positive T cells, donor2	11938-126A3	1240.37	23.53	0.75	0.37	1.49	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	956.18	73.29	4.86	4.65	0.42	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	1358.75	49.51	1.16	1.74	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	847.32	99.85	0.49	0.66	0.33	0.49
gastric cancer cell line:GSS	10560-108A2	1129.39	64.98	1.83	0.00	0.92	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	993.79	54.60	1.60	1.83	0.91	0.46
giant cell carcinoma cell line:LU65	10487-107B1	1881.40	110.84	1.61	1.49	3.56	1.15
giant cell carcinoma cell line:Lu99B	10433-106E1	630.66	33.45	0.14	0.00	0.28	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	546.97	48.14	1.00	0.25	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	349.27	36.31	0.32	0.11	0.32	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	341.27	36.09	0.00	0.56	1.26	0.70
glioblastoma cell line:T98G	10485-107A8	581.01	32.12	0.22	0.77	0.44	0.11
glioma cell line:GI-1	10413-106B8	831.19	21.97	0.29	0.00	1.17	1.17
globus pallidus - adult, donor10196	10175-103C4	256.58	14.58	0.00	0.00	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	354.91	8.54	0.00	0.49	0.24	0.73
globus pallidus, adult, donor10258	10367-105F7	323.13	6.85	0.00	1.37	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	345.86	26.11	0.00	2.13	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	521.24	58.73	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	3125.52	163.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	4421.69	344.95	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	359.03	23.68	0.64	1.28	0.32	0.32
hIPS +CCl2, biol_rep1	14383-156B9	438.00	181.81	2.30	1.84	0.46	1.38
hIPS +CCl2, biol_rep2	14384-156C1	571.12	197.99	3.20	0.91	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	622.19	229.30	1.29	0.64	0.00	1.29
hIPS, biol_rep1	14380-156B6	248.65	320.52	2.87	1.44	0.00	1.44
hIPS, biol_rep2	14381-156B7	532.23	181.75	1.37	0.00	0.69	1.37
hIPS, biol_rep3	14382-156B8	131.31	41.93	0.00	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	638.76	59.48	1.72	0.86	0.86	0.29
heart - mitral valve, adult	10205-103F7	458.92	8.67	0.30	1.20	1.20	0.60
heart - pulmonic valve, adult	10206-103F8	499.42	14.90	0.26	0.52	0.52	0.26
heart - tricuspid valve, adult	10207-103F9	462.12	29.98	0.83	0.00	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	617.07	30.81	1.84	1.02	0.20	0.00
heart, adult, diseased, donor1	10051-101G6	469.69	2.98	1.28	2.55	0.00	0.00
heart, adult, pool1	10016-101C7	726.73	8.28	1.84	0.69	0.46	0.23
heart, fetal, pool1	10046-101G1	1034.60	13.45	0.41	0.51	0.72	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	438.10	11.42	0.31	0.62	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	832.42	23.78	0.00	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	728.72	102.43	0.99	1.22	0.33	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	749.12	118.34	1.34	0.73	0.12	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	712.73	104.89	0.81	0.30	0.51	0.51
hepatoma cell line:Li-7	10484-107A7	903.52	157.15	0.22	0.67	2.34	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	1015.36	180.00	1.41	1.51	0.70	1.61
hippocampus - adult, donor10196	10169-103B7	145.73	15.14	0.95	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	264.11	7.35	0.41	1.02	0.61	0.00
hippocampus, adult, donor10258	10374-105G5	126.98	14.94	0.00	0.00	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	182.58	18.33	0.35	0.70	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	1739.48	231.32	14.04	7.32	1.22	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	1573.78	119.58	5.30	1.96	0.39	1.37
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	1332.70	139.13	7.87	2.54	0.25	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	1318.88	46.80	5.64	2.82	1.13	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	1771.59	47.77	14.98	8.26	2.32	4.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	1685.85	55.42	7.59	3.04	0.76	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	932.21	56.93	5.84	5.26	0.29	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	1176.89	44.59	6.03	3.02	1.08	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	801.62	59.64	4.17	2.92	0.83	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	1080.49	104.43	1.18	0.24	1.89	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	1021.20	87.43	4.66	2.89	0.16	1.61
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	1044.29	115.13	0.67	0.00	2.02	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	1450.77	87.16	6.89	2.50	0.94	1.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	1451.28	123.81	14.74	6.88	0.98	4.42
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	1598.01	118.69	15.71	9.60	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	1303.92	32.45	4.20	2.29	1.15	1.34
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	963.29	34.01	1.31	2.18	0.44	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	1174.94	37.98	9.00	5.50	0.50	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	1235.66	26.94	6.22	2.45	3.39	1.70
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	1040.39	35.92	5.46	2.27	0.45	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	1061.56	26.94	3.76	3.76	0.31	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	793.16	47.85	2.94	1.80	1.96	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	652.62	53.42	2.90	2.32	0.87	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	667.79	51.41	3.89	5.08	0.30	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	1314.46	76.48	5.91	1.29	0.92	1.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	1041.00	72.18	2.57	2.57	0.57	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	1417.25	122.49	9.39	2.45	0.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	830.56	34.86	2.46	3.87	0.35	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	859.00	33.57	3.17	2.53	0.32	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	932.37	32.99	4.54	0.30	0.61	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	724.49	31.54	2.07	2.07	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	753.16	31.88	3.98	1.99	0.66	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	767.55	38.48	2.82	2.31	0.00	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	658.55	56.24	2.81	0.77	0.26	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	737.54	69.66	1.51	1.51	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	659.34	65.53	4.70	2.69	0.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	1149.81	79.70	5.80	2.17	0.97	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	1399.37	112.75	12.03	2.67	0.00	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	1177.57	96.59	8.78	5.37	0.49	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	917.46	25.06	1.83	1.53	0.61	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	1154.90	61.81	9.76	13.01	3.25	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	1249.31	39.05	5.96	3.31	0.33	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	857.07	39.95	0.00	1.64	0.55	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	942.71	39.45	2.90	2.17	0.00	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	790.04	30.60	2.85	1.78	0.71	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	539.41	51.32	0.00	1.19	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	722.90	48.08	0.68	0.68	1.76	0.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	626.88	54.96	1.35	1.35	0.00	0.54
immature langerhans cells, donor1	11904-125F5	971.49	191.30	0.48	1.21	0.48	0.24
immature langerhans cells, donor2	11905-125F6	779.46	81.59	1.58	3.17	0.00	0.00
insula, adult, pool1	10039-101F3	246.33	8.90	0.00	0.00	0.28	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	740.69	54.95	2.28	0.65	0.00	0.33
kidney, adult, pool1	10017-101C8	514.15	17.82	0.40	0.20	0.40	0.60
kidney, fetal, pool1	10045-101F9	801.15	20.16	0.28	0.35	0.71	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	1047.40	106.23	0.57	0.43	2.41	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	2654.38	180.54	5.11	5.25	0.41	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	1002.28	40.92	0.37	0.92	0.92	0.00
left atrium, adult, donor1	10079-102A7	539.95	7.63	0.54	2.18	0.00	0.00
left ventricle, adult, donor1	10078-102A6	524.36	20.23	1.52	2.02	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	696.61	88.65	1.37	1.37	1.37	0.82
leiomyoma cell line:10964C	10569-108B2	500.07	37.72	2.87	1.08	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	304.89	41.85	0.54	1.63	0.00	1.09
leiomyoma cell line:15425	10571-108B4	379.76	36.42	1.46	1.46	0.00	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	590.49	50.79	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	1223.30	56.46	6.27	3.14	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	1371.72	208.14	1.30	1.30	1.18	1.18
liposarcoma cell line:KMLS-1	10782-110G8	502.06	17.96	1.41	0.94	1.09	1.09
liposarcoma cell line:SW 872	10726-110A6	467.01	64.33	0.49	0.24	0.24	0.61
liver, adult, pool1	10018-101C9	708.69	27.23	0.81	0.16	0.16	0.00
liver, fetal, pool1	10086-102B5	449.66	33.87	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	199.78	8.75	0.00	0.15	0.15	0.29
locus coeruleus, adult, donor10252	10165-103B3	279.04	9.04	0.92	0.18	0.74	0.37
locus coeruleus, adult, donor10258	10375-105G6	290.04	16.36	1.97	0.56	0.00	0.28
locus coeruleus, newborn, donor10223	10362-105F2	250.69	29.86	0.84	0.42	0.00	1.26
lung adenocarcinoma cell line:A549	10499-107C4	1189.64	72.10	0.42	0.69	1.38	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	506.71	41.36	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	589.75	41.39	1.58	0.40	0.26	0.26
lung, adult, pool1	10019-101D1	791.69	11.81	0.47	0.47	0.24	0.59
lung, fetal, donor1	10068-101I5	413.84	10.85	0.00	1.14	0.57	0.29
lung, right lower lobe, adult, donor1	10075-102A3	733.60	14.66	3.67	2.29	0.46	0.46
lymph node, adult, donor1	10077-102A5	1189.09	29.35	5.68	2.37	1.42	1.42
lymphangiectasia cell line:DS-1	10727-110A7	1253.04	109.59	2.63	3.07	0.00	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	1417.35	144.74	1.06	0.91	5.13	1.96
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	469.77	61.16	2.55	1.70	5.10	0.00
mature adipocyte, donor1	12231-129F8	496.38	8.88	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	506.58	12.87	0.62	0.00	0.42	0.00
mature adipocyte, donor3	12233-129G1	403.01	9.96	0.00	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	624.09	16.32	0.00	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	901.10	44.55	0.48	0.24	0.71	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	127.47	6.77	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	210.76	5.89	0.37	0.55	0.37	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	118.82	10.17	0.32	0.64	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	211.11	22.60	0.43	0.00	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	189.17	10.46	0.84	0.84	0.17	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	206.92	6.15	0.00	0.42	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	63.57	15.41	1.93	0.00	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	129.18	43.06	0.00	0.00	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	188.44	20.10	0.00	0.00	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	246.61	14.28	1.95	0.00	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	281.12	4.95	0.00	0.46	0.31	0.15
medulla oblongata, adult, pool1	10038-101F2	282.84	8.49	0.08	0.08	0.24	0.16
medulla oblongata, newborn, donor10223	10361-105F1	303.44	17.01	1.39	0.69	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	1758.68	63.55	3.99	1.99	1.33	0.22
medulloblastoma cell line:ONS-76	10759-110E3	630.93	99.53	0.98	0.37	0.61	0.37
melanoma cell line:COLO 679	10514-107E1	512.74	64.25	1.15	0.43	0.29	0.29
melanoma cell line:G-361	10465-106H6	1118.97	179.98	5.70	1.09	12.49	4.07
meningioma cell line:HKBMM	10691-109F7	640.40	37.99	3.80	2.53	0.18	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	921.69	65.21	4.41	6.17	7.93	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	552.15	104.47	2.59	2.33	1.04	1.81
mesenchymal precursor cell - adipose, donor1	11747-123G1	657.31	65.52	1.38	1.07	0.31	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	716.03	15.81	2.18	0.91	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	338.74	33.54	0.41	0.00	0.00	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	448.82	12.08	0.84	0.42	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	648.18	10.98	0.77	0.77	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	359.53	23.60	0.00	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	567.42	27.46	1.54	0.86	0.00	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	522.63	20.93	1.15	0.58	0.00	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	491.82	36.74	0.40	0.13	0.00	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	436.18	53.88	0.68	0.14	0.00	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	338.73	20.49	0.85	0.14	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	472.29	12.52	0.33	0.00	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	530.66	24.49	0.55	0.28	0.14	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	362.70	35.61	0.35	0.70	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	450.39	19.40	0.61	1.02	0.00	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	338.25	18.33	0.36	0.72	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	411.52	6.72	0.62	0.31	0.10	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	211.12	23.26	0.68	0.23	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	261.38	52.44	1.26	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	488.21	24.81	0.45	0.45	0.30	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	444.83	12.08	0.88	0.53	0.09	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	425.59	8.47	0.74	1.10	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	306.19	22.32	0.29	0.86	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	651.31	51.78	4.21	5.05	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	645.28	30.14	0.91	0.91	0.46	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	571.68	26.86	1.53	0.51	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	587.64	34.03	0.52	1.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	517.28	22.80	0.62	0.62	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	547.20	25.65	3.53	0.71	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	587.56	25.05	2.03	0.68	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	580.81	20.43	1.57	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	525.94	23.63	1.39	0.46	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	627.95	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	671.44	33.46	1.73	1.44	0.29	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	549.50	25.43	1.56	0.22	0.22	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	604.48	21.63	0.72	2.16	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	581.53	35.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	564.57	24.17	0.67	0.67	0.00	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	527.28	22.52	1.64	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	524.49	21.91	0.86	1.72	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	757.43	46.48	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	609.47	20.66	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	681.73	34.43	2.60	1.95	0.32	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	650.38	40.74	4.36	1.45	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	753.77	38.38	1.60	0.53	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	676.30	37.62	2.45	1.64	0.00	3.27
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	638.28	28.38	1.55	0.78	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	663.20	33.58	4.20	0.00	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	727.22	34.77	0.99	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	629.27	61.97	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	629.73	28.46	3.56	1.19	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	640.91	25.59	4.87	1.22	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	378.73	81.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	724.59	27.24	0.00	2.53	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	741.54	21.73	2.76	1.03	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	773.71	27.94	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	846.26	7.98	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	733.55	41.33	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	933.11	30.56	2.44	1.22	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	937.44	23.04	6.36	2.38	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	989.23	18.86	1.77	3.54	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	967.53	24.62	3.12	1.87	0.00	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	961.07	25.40	0.00	5.35	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	866.90	31.93	5.91	2.37	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	785.81	38.52	2.57	5.14	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	930.02	49.56	4.13	2.07	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	730.34	30.18	4.95	0.99	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	708.79	30.28	2.24	4.49	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	770.27	45.16	3.18	1.91	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	540.00	18.54	0.81	0.40	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	523.34	21.81	13.08	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	548.64	22.81	1.27	3.80	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	389.01	9.10	1.82	1.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	582.95	22.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	469.50	16.47	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	697.47	18.26	0.40	1.59	2.38	1.39
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	628.22	15.90	3.89	1.62	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	624.42	22.41	6.11	2.04	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	459.59	11.61	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	456.18	23.86	0.24	0.24	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	867.15	104.72	0.70	2.09	1.62	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	730.78	123.93	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	1976.61	221.32	1.95	1.13	0.31	0.62
mesothelioma cell line:Mero-25	10850-111F4	741.00	117.56	1.82	1.59	0.45	0.45
mesothelioma cell line:Mero-41	10851-111F5	777.43	68.94	1.47	1.96	0.73	0.00
mesothelioma cell line:Mero-48a	10852-111F6	457.03	71.74	1.33	0.89	0.44	0.22
mesothelioma cell line:Mero-82	10853-111F7	1104.83	88.30	1.58	1.05	0.26	1.05
mesothelioma cell line:Mero-83	10854-111F8	760.38	49.87	2.38	0.68	0.34	0.68
mesothelioma cell line:Mero-84	10855-111F9	618.79	99.34	1.26	1.26	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	615.54	61.08	2.90	1.66	0.21	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	700.03	47.04	0.83	1.33	0.17	0.17
mesothelioma cell line:NCI-H226	10846-111E9	746.59	114.93	1.63	1.27	0.00	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	253.67	31.09	0.17	0.51	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	784.26	60.31	1.78	0.76	0.51	0.25
mesothelioma cell line:No36	10857-111G2	895.75	108.63	2.61	0.98	0.33	0.65
mesothelioma cell line:ONE58	10858-111G3	326.77	28.99	1.63	0.54	0.00	1.08
migratory langerhans cells, donor1	11901-125F2	611.47	27.83	1.15	0.38	1.15	0.38
migratory langerhans cells, donor2	11902-125F3	440.96	20.76	0.37	0.49	1.22	0.61
migratory langerhans cells, donor3	11903-125F4	738.74	14.00	0.54	0.36	0.18	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	503.10	62.03	4.24	2.29	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	530.90	141.57	1.48	2.12	0.42	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	848.87	140.98	0.69	0.92	0.69	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	652.32	37.11	0.76	0.57	0.19	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	2054.15	165.57	1.66	1.66	7.21	1.66
myeloma cell line:PCM6	10474-106I6	1243.33	96.26	0.99	0.99	6.33	1.78
myxofibrosarcoma cell line:MFH-ino	10600-108E6	713.25	76.60	1.01	2.03	1.52	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	413.46	28.44	0.00	0.00	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	1338.66	58.72	0.22	0.78	0.22	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	1226.95	70.16	0.88	0.29	0.59	0.15
nasal epithelial cells, donor2	12227-129F4	641.41	22.63	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	1617.10	49.23	0.92	0.46	2.53	0.23
neuroblastoma cell line:NB-1	10539-107G8	680.06	100.65	0.19	0.19	0.19	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	730.94	78.24	1.69	0.84	0.42	0.63
neuroblastoma cell line:NH-12	10555-107I6	1658.15	55.91	1.49	1.30	0.93	1.49
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	786.17	29.89	1.90	0.95	0.24	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	1025.83	26.61	4.12	3.33	0.63	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	1035.28	85.74	2.62	2.62	1.01	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	685.99	34.97	0.64	2.54	0.00	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	444.23	29.28	1.06	0.80	1.06	0.53
neutrophil PMN, donor1	12133-128D9	74.37	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	278.89	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	483.00	18.94	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	1179.78	47.52	0.34	0.51	1.35	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	1522.57	325.81	0.00	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	653.40	37.83	2.56	1.28	0.32	2.89
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	527.37	23.65	1.58	0.53	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	219.07	10.69	0.00	0.00	0.19	0.00
occipital cortex - adult, donor10196	10172-103C1	152.47	12.36	0.00	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	288.22	7.51	0.27	1.88	0.54	0.54
occipital cortex, newborn, donor10223	10355-105E4	213.27	16.74	0.36	0.00	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	262.14	12.60	0.52	0.52	0.52	0.26
occipital lobe, fetal, donor1	10073-102A1	936.30	18.88	1.72	1.29	2.57	0.86
occipital pole, adult, pool1	10036-101E9	228.09	7.57	0.08	0.08	0.32	0.00
olfactory region, adult	10195-103E6	185.32	6.69	0.38	0.76	0.38	0.00
optic nerve, donor1	10277-104E7	288.15	14.01	0.00	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	683.33	46.02	0.46	0.23	0.34	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	1215.46	47.81	0.14	0.82	0.69	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	769.41	42.84	3.05	3.39	0.34	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	773.22	58.56	0.92	0.35	0.23	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	451.83	13.23	0.59	1.18	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	1057.67	96.24	0.93	2.80	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	625.36	37.53	0.21	0.00	0.85	0.00
ovary, adult, pool1	10020-101D2	1354.12	19.13	0.96	0.52	0.44	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	511.46	89.46	1.65	2.20	0.92	0.55
pancreas, adult, donor1	10049-101G4	2626.26	56.44	4.70	1.88	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	1137.43	33.26	1.12	2.24	0.84	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	774.09	61.33	3.92	6.13	0.17	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	951.60	81.30	0.50	0.33	0.83	0.66
paracentral gyrus, adult, pool1	10035-101E8	195.58	8.88	0.00	0.09	0.27	0.00
parietal cortex, adult, donor10258	10373-105G4	126.98	15.41	0.73	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	144.83	6.58	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	204.09	5.99	0.00	0.86	0.57	0.00
parietal lobe, adult, pool1	10034-101E7	215.19	9.16	0.09	0.00	0.09	0.09
parietal lobe, fetal, donor1	10072-101I9	847.64	17.46	3.88	1.94	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	190.29	15.33	0.37	0.00	0.37	0.37
parotid gland, adult	10199-103F1	1045.86	8.63	2.47	4.93	0.00	0.00
penis, adult	10200-103F2	791.70	10.74	2.15	3.76	2.69	3.76
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	654.68	32.35	0.93	1.12	0.74	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	355.06	22.15	0.44	0.29	0.00	0.29
pineal gland - adult, donor10196	10179-103C8	119.33	12.90	0.00	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	212.60	11.84	0.00	0.00	1.78	0.59
pineal gland, adult, donor10258	10377-105G8	223.24	18.81	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	309.61	20.24	0.00	1.01	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	380.46	15.11	1.04	0.52	2.61	0.00
pituitary gland, adult, donor10258	10378-105G9	635.03	30.64	0.85	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	553.32	22.15	0.43	0.32	0.43	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	1258.06	75.48	2.65	1.99	0.66	1.19
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	503.96	18.68	0.47	0.78	1.40	0.16
pons, adult, pool1	10033-101E6	176.35	6.28	0.00	0.09	0.09	0.09
postcentral gyrus, adult, pool1	10032-101E5	296.83	10.37	0.00	0.17	0.35	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	192.41	6.27	0.00	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	3051.45	148.72	0.00	11.02	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	3685.03	234.72	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	1036.82	46.47	0.44	1.02	2.33	0.29
prostate cancer cell line:PC-3	10439-106E7	522.18	39.93	0.36	0.36	2.18	0.36
prostate, adult, pool1	10022-101D4	845.88	7.26	1.09	0.27	1.27	0.09
putamen, adult, donor10196	10176-103C5	297.20	13.22	0.24	1.18	0.00	0.94
putamen, adult, donor10252	10152-102I8	501.95	11.76	0.00	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	169.39	104.91	1.09	0.00	0.00	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	218.42	11.11	0.97	0.00	0.24	0.00
putamen, newborn, donor10223	10365-105F5	254.88	28.49	0.75	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	490.81	23.86	0.29	0.29	0.29	0.29
rectum, fetal, donor1	10067-101I4	1315.88	23.65	0.00	1.39	2.78	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	653.17	33.50	0.42	0.42	0.21	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	480.90	8.70	0.83	0.83	3.31	1.24
retina, adult, pool1	10030-101E3	593.71	8.85	0.10	0.20	0.60	0.20
retinoblastoma cell line:Y79	10475-106I7	1253.55	63.91	0.26	2.08	1.04	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	561.14	99.96	0.25	1.11	0.74	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	1658.80	144.82	0.84	0.56	1.97	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	579.76	9.09	0.00	2.27	0.76	0.00
salivary acinar cells, donor1	11771-123I7	753.77	29.62	1.62	0.81	0.49	0.16
salivary acinar cells, donor2	11772-123I8	1139.50	27.81	6.61	0.96	0.14	0.69
salivary acinar cells, donor3	11773-123I9	498.52	10.59	0.66	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	562.80	12.58	1.14	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	302.26	10.12	0.00	0.34	0.08	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	349.60	8.70	0.12	0.00	1.76	0.24
seminal vesicle, adult	10201-103F3	560.29	22.22	3.17	11.11	1.06	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	308.27	27.94	1.46	0.73	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	515.85	23.15	2.01	0.75	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	492.73	50.18	2.01	2.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	1264.49	52.79	0.94	1.07	0.54	0.94
signet ring carcinoma cell line:Kato III	10436-106E4	433.27	45.32	0.33	0.11	0.22	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	637.64	64.13	0.00	0.39	1.42	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	423.47	26.95	1.42	3.55	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	1256.10	32.02	1.08	1.92	1.08	0.00
skeletal muscle, fetal, donor1	10066-101I3	1388.93	41.21	2.01	6.03	1.01	1.01
skin, adult, donor1	10074-102A2	712.45	20.36	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	657.74	17.04	1.89	0.63	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	1749.66	281.83	4.67	5.34	1.33	2.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	787.38	97.40	1.58	2.52	0.32	1.58
small cell lung carcinoma cell line:DMS 144	10841-111E4	1823.97	74.21	4.05	2.51	1.16	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	728.21	53.57	0.16	0.16	1.48	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	2148.63	32.01	2.57	2.73	1.45	2.41
small cell lung carcinoma cell line:WA-hT	10562-108A4	309.01	65.38	0.00	0.22	0.44	0.00
small intestine, adult, pool1	10024-101D6	867.99	22.81	0.48	0.60	1.07	0.24
small intestine, fetal, donor1	10064-101I1	781.56	21.38	2.21	2.70	0.00	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	880.14	57.44	6.15	4.10	0.51	1.03
smooth muscle, adult, pool1	10048-101G3	691.63	6.98	1.29	1.81	0.78	0.00
somatostatinoma cell line:QGP-1	10781-110G7	585.89	97.56	0.27	0.27	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	253.95	11.93	0.69	1.38	0.92	0.23
spinal cord, adult, donor10252	10159-103A6	275.60	4.34	1.58	0.00	1.58	0.39
spinal cord, adult, donor10258	10369-105F9	198.55	15.91	0.69	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	493.97	12.20	0.61	1.83	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	340.74	22.04	1.84	0.00	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	434.02	27.93	0.30	0.60	0.30	0.15
spleen, adult, pool1	10025-101D7	820.72	22.25	1.10	0.33	0.55	0.11
spleen, fetal, pool1	10044-101F8	630.24	20.74	0.64	0.40	0.79	0.40
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	1001.38	91.19	0.31	0.31	0.52	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	353.93	45.95	0.19	0.19	2.09	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	654.17	65.70	1.75	0.70	0.00	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	1387.02	83.66	3.13	3.52	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	780.48	109.07	0.56	0.11	1.58	0.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	1375.44	154.19	1.27	3.39	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	552.11	57.54	0.00	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	1226.03	38.45	3.20	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	955.35	13.10	5.13	6.84	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	217.10	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	355.38	8.10	0.21	0.83	1.04	0.21
substantia nigra, adult, donor10258	10371-105G2	106.55	19.14	0.52	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	231.76	19.08	0.00	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	1139.45	98.58	0.92	1.83	4.59	0.69
temporal lobe, adult, pool1	10031-101E4	289.07	11.02	0.17	0.17	0.59	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	714.40	14.96	2.14	4.99	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	588.10	16.70	1.76	2.64	0.88	0.44
tenocyte, donor1	11763-123H8	541.80	23.04	1.05	1.40	0.35	0.00
tenocyte, donor2	11765-123I1	545.93	11.45	1.14	0.76	0.00	0.00
tenocyte, donor3	11768-123I4	454.81	29.28	2.97	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	646.36	117.95	1.36	0.85	1.53	1.19
teratocarcinoma cell line:NCR-G1	10798-110I6	906.55	79.54	4.62	1.70	0.46	1.54
teratocarcinoma cell line:PA-1	10807-111A6	968.61	65.71	1.70	1.86	1.08	2.48
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	847.75	81.37	2.54	1.65	0.89	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	1286.16	68.83	1.51	1.51	0.38	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	669.75	40.03	0.98	0.98	0.76	0.87
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	981.67	113.34	3.58	1.95	0.33	0.98
testis, adult, pool1	10026-101D8	579.17	20.19	0.75	0.43	1.72	0.21
testis, adult, pool2	10096-102C6	368.54	32.48	2.26	1.80	0.45	0.00
thalamus - adult, donor10196	10168-103B6	198.72	12.14	2.21	1.10	1.10	0.00
thalamus, adult, donor10252	10154-103A1	310.22	5.63	0.16	0.63	0.31	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	109.31	29.25	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	188.24	9.39	0.66	1.32	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	127.72	18.99	0.58	0.58	0.00	0.00
throat, adult	10209-103G2	662.12	18.48	2.75	2.75	1.50	0.25
throat, fetal, donor1	10061-101H7	819.05	23.77	3.05	5.79	0.00	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	760.94	88.83	1.19	0.60	0.00	0.40
thymus, adult, pool1	10027-101D9	1034.91	26.05	1.79	0.60	2.68	0.40
thymus, fetal, pool1	10043-101F7	668.00	12.68	0.94	0.42	0.62	0.73
thyroid carcinoma cell line:KHM-5M	10776-110G2	982.98	83.63	2.39	1.33	0.13	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	1742.36	72.22	3.21	2.37	1.26	1.68
thyroid, adult, pool1	10028-101E1	890.86	18.48	1.21	1.40	1.87	0.28
thyroid, fetal, donor1	10060-101H6	491.73	33.49	1.05	3.95	1.05	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	418.83	9.24	3.08	6.16	12.32	3.08
tongue, adult	10203-103F5	989.85	41.63	4.88	3.26	0.70	0.93
tongue, fetal, donor1	10059-101H5	983.26	26.80	2.36	3.15	0.00	0.39
tonsil, adult, pool1	10047-101G2	1150.92	34.16	0.10	0.70	0.80	0.40
trachea, adult, pool1	10029-101E2	638.03	32.07	0.16	0.65	1.06	0.16
trachea, fetal, donor1	10058-101H4	595.51	24.24	1.54	1.15	0.38	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	509.80	63.77	1.42	1.42	0.71	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	631.20	70.92	0.71	0.41	0.61	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	776.70	32.12	0.63	0.78	2.19	0.47
tridermal teratoma cell line:HGRT	10694-109G1	445.19	17.12	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	733.67	46.39	1.78	0.76	0.68	0.42
umbilical cord, fetal, donor1	10057-101H3	555.01	16.69	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	504.72	12.11	0.68	0.51	0.51	1.19
uterus, fetal, donor1	10055-101H1	766.36	19.97	1.02	2.05	1.02	0.51
vagina, adult	10204-103F6	896.28	4.52	1.94	0.00	0.00	0.00
vein, adult	10191-103E2	978.72	14.25	1.75	4.60	0.00	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	914.07	46.20	1.34	1.87	0.27	0.00

Property "Nearest transcripts" (as page type) with input value "ENST00000601390.1:89 AK055869:89 AK315498:89 D28392:89 BC004324:91 ENST00000601655.5:96 BC095429:96 ENST00000339471.8:101 M60854:103 BC007977:106 BC071674:106 BC024970:121 ENST00000599539.5:122 DQ893449:140 DQ896219:140 CU678668:141 KJ892061:141 KJ905911:141 CU687136:141 KJ901716:141 ENST00000599705.1:332" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.